Tag Archives: FDI

AI-Related Inventions and Trademark Evidence in China: The September 2026 Examination Standards

  • China’s new Patent Examination Guidelines, in force since 1 January 2026, require that the inventor be a natural person and that an artificial-intelligence system may not be named as an inventor; the guidelines also establish a “holistic determination” approach to assessing patentable subject matter.
    自2026年1月1日施行的新版《专利审查指南》要求发明人必须是自然人,请求书中不得填写人工智能名称,并确立了判断专利保护客体的”整体判断”原则。
  • The Supreme People’s Court’s Opinion on adjudicating artificial-intelligence-related disputes, issued on 7 September 2026, provides in Article 14 that an AI-related invention which “adopts technical means that follow the laws of nature, solves a technical problem and achieves a technical effect consistent with the laws of nature” is protected as a patent-eligible subject matter; the protection is for human creativity, not machine output.
    最高人民法院于2026年9月7日发布的《关于依法审理涉人工智能纠纷案件的意见》第14条明确:涉人工智能发明创造”采用遵循自然规律的技术手段,解决了技术问题,实现了符合自然规律的技术效果的”,依法认定为专利法所保护的客体;专利保护的是人的创造性,而非机器的产出。
  • The administrative rules and the judicial rules now converge for the first time on the question of AI inventions: both insist that patent protection attaches to human inventiveness, while leaving the door open for AI-assisted technical solutions that meet the three-element test of means, problem and effect.
    行政审查规则与司法裁判规则在人工智能发明创造问题上首次形成呼应:二者均强调专利保护指向人的创造性,同时为满足”手段—问题—效果”三要素的人工智能辅助技术方案保留通道。
  • The 15th Five-Year Plan for intellectual-property protection and utilisation calls for improving the protection rules for algorithms, artificial-intelligence-generated outputs and matters related to platform-economy development, signalling a forward-looking policy direction for AI-related IP.
    《知识产权保护和运用”十五五”规划》提出”完善算法、人工智能生成物以及与平台经济发展相关的知识产权保护规则”,为人工智能相关知识产权指明了前瞻性政策方向。
  • The revised Measures for the Prioritised Examination of Patents (Order No. 85) took effect on 1 September 2026, steering fast-track resources toward emerging industries, future industries and key-core-technology breakthroughs; a 26 August 2026 implementation notice clarifies the transition between the old and new regimes.
    新修订《专利优先审查管理办法》(局令第85号)自2026年9月1日起施行,优先审查资源向新兴产业、未来产业和关键核心技术攻关倾斜;2026年8月26日的实施工作通知明确了新旧办法的衔接安排。
  • In trademark practice, the “three-year non-use cancellation” procedure is placing greater weight on electronically admissible evidence that forms a traceable, mutually corroborating chain — contracts, orders, payments, logistics, platform pages and promotional records — narrowing the room for fabricated transaction invoices or formalistic orders to manufacture a veneer of use.
    商标审查中的”连续三年不使用撤销”程序更加重视可采信的电子证据,强调形成可追溯、相互印证的完整链条(合同、订单、付款、物流、平台页面、宣传记录),压缩了以虚假交易发票或形式化订单制造”使用痕迹”的空间。
  • Practical compliance for foreign innovators and brand owners means documenting the human contribution in AI-assisted filings, retaining R&D and data-source trail, preparing a use-evidence archive per mark, and building a defensible evidence chain before any cancellation challenge arises.
    对境外创新主体与品牌权利人而言,实务合规意味着在人工智能辅助申请中记录人的贡献、留存研发与数据来源痕迹、为核心商标建立使用证据档案,并在面临撤销挑战前构建可抗辩的证据链。

AI-Related Inventions and Trademark Evidence in China: The September 2026 Examination Standards | 人工智能相关发明创造的专利确权边界与商标使用证据要求(2026年9月)/ AI-Related Inventions and Trademark Evidence in China

Overview

September 2026 is a notable moment for intellectual-property protection in China: within the same year, the administrative and judicial branches have both drawn the boundary around artificial-intelligence-related creations so as to protect human inventiveness while accommodating AI-assisted technical solutions. The revised Patent Examination Guidelines in force since 1 January 2026 set out who may be named as an inventor and how patentable subject matter is assessed. The Supreme People’s Court’s Opinion on adjudicating AI-related disputes, released on 7 September 2026, gives courts a dedicated rule — Article 14 — on when an AI-related invention is patent-eligible. Around this core, the 15th Five-Year Plan for IP protection (state document No. 30 of 2026) sets a forward-looking direction, the revised Measures for the Prioritised Examination of Patents (Order No. 85) took effect on 1 September 2026, and trademark use-evidence standards are tightening in practice. The combined message for foreign filers: protect and prove human creativity, and keep the documentary trail that demonstrates it.

Administrative examination: the inventor must be human

The revised Patent Examination Guidelines, effective from 1 January 2026, address artificial intelligence directly. First, the inventor must be a natural person; the request form may not list an AI system as an inventor. The legal status of “inventor” is reserved for human beings, and an AI tool is treated as an instrument of the human inventor. Second, the guidelines establish a “holistic determination” (整体判断) principle: the examiner weighs the invention as a whole against the statutory criteria rather than isolating a single feature. This matters for AI-related applications, where the contribution may lie in how a model, algorithm or data pipeline is applied to a concrete technical problem. Applicants should present the solution as an integrated technical whole, not as a bare claim to an abstract idea or to a machine’s output, and should ensure the named inventors are identifiable natural persons.

Judicial stance: the Supreme People’s Court Opinion of September 2026

On 7 September 2026, the Supreme People’s Court issued the Opinion on Adjudicating Cases Involving Disputes over Artificial Intelligence, the first judicial adjudication rule document on AI issued by the country’s highest judicial organ. Its Part Three (Articles 12–16) deals specifically with IP disputes, covering infringement liability, open-source software, patent grant and validity, technology-contract performance and data-use norms.

Article 14 is the provision most directly relevant to patents. It provides that an AI-related invention which “adopts technical means that follow the laws of nature, solves a technical problem and achieves a technical effect consistent with the laws of nature” is, pursuant to law, a subject matter protected by the patent law. The test is the familiar three-element inquiry — technical means, technical problem, technical effect — applied to AI-related subject matter, and the Opinion makes explicit that the patent system protects human creativity, not machine output. This aligns the judicial threshold with the administrative “holistic determination” principle, gives courts a stable published rule, and closes the gap that had existed between how examiners and judges might treat AI-assisted inventions.

Policy layer and prioritised examination

The 15th Five-Year Plan for the Protection and Utilisation of Intellectual Property (State Council document No. 30 of 2026, issued on 27 July 2026) calls for improving protection rules for algorithms, AI-generated outputs and platform-economy matters, and for continuously improving patent-related legal systems. It signals that AI-related IP rules are still being built, on a trajectory of clearer, more purposive protection rather than exclusion.

The revised Measures for the Prioritised Examination of Patents (Order No. 85), effective from 1 September 2026, replace the 2017 version and steer fast-track resources toward high-value applications — those involving emerging industries, future industries or key-core-technology breakthroughs, or industries encouraged by provincial or city-level governments, among other grounds — while imposing sanctions for conduct violating the principle of good faith. A 26 August 2026 implementation notice clarifies the transition: requests submitted from 1 September 2026 follow the new Measures, earlier ones follow the original; re-examination or invalidation prioritised-examination requests are filed online via the “patent事务服务” module of the patent business-processing system; and the new Prioritised Examination Request form applies from 1 September 2026.

Trademark side: use evidence and the three-year non-use cancellation

On the trademark front, the “three-year non-use cancellation” procedure (撤三) is where evidentiary discipline is tightening most visibly. A registered mark not genuinely used for three consecutive years without proper reason may be cancelled on petition, and examination now places greater weight on electronically admissible materials that form a traceable, mutually corroborating chain: a contract, its order, the payment record, the logistics proof, the platform listing and the promotional record should each corroborate the others. An isolated invoice is no longer enough; fabricated transaction invoices, formalistic orders lacking real performance, or defensive “affiliation” arrangements meant merely to manufacture a semblance of use are being squeezed out.

This direction is reinforced by the revised Trademark Law, adopted on 26 June 2026 and taking effect on 1 January 2027 — the first comprehensive amendment since 1983. It writes the principle of good faith into the statute, tightens the registration gate against hoarding and squatting, and strengthens supervision of trademark agencies. For foreign brand owners, stricter use-evidence expectations plus a good-faith statutory regime mean documented, genuine commercial use is the safest way both to keep a mark alive and to defeat a non-use cancellation petition.

Practical steps for applicants

For AI-related patent filings: (1) record the human contribution — ensure named inventors are natural persons and keep internal logs of who directed and performed the inventive work; (2) draft to the three-element test, articulating technical means, problem and effect as an integrated solution; (3) retain the R&D and data-source trail, documenting provenance and licences of any training data; (4) prepare office-action responses early, assembling search reports and prior-art material to show, holistically, why the solution is a lawful technical contribution.

For trademark protection: (1) build a use-evidence archive per core mark, keeping dated contracts, orders, payments, logistics, platform listings and promotional materials; (2) make the chain self-corroborating with independent sources such as platform pages or customs records; (3) tie defensive registrations to real commercial plans, since filings beyond normal business needs carry rejection and bad-faith risk; (4) prepare the cancellation-defence package in advance rather than waiting for a 撤三 petition.

Related reading

  • The revised Patent Examination Guidelines (effective 1 January 2026) on inventor status and subject-matter assessment.
  • The Supreme People’s Court Opinion on adjudicating AI-related disputes (7 September 2026), Part Three on IP disputes.
  • The 15th Five-Year Plan for the Protection and Utilisation of Intellectual Property (State Council document No. 30 of 2026).
  • The revised Measures for the Prioritised Examination of Patents (Order No. 85, effective 1 September 2026).

Sources

  • 国家知识产权局(官网): https://www.cnipa.gov.cn/
  • 林州市人民政府(新版《专利优先审查管理办法》全文转载): https://www.linzhou.gov.cn/2026/09-07/3658810.html
  • 浙江省市场监督管理局(浙江省知识产权局)《关于做好〈专利优先审查管理办法〉有关实施工作的通知》转载: https://zjamr.zj.gov.cn/col/col1229094027/art/2026/art_c86f0eda26b8439d806be9a748519f47.html
  • 最高人民法院(官网): https://www.court.gov.cn/
  • 最高人民法院知识产权法庭《以人为本 智能向善——聚焦〈最高人民法院关于依法审理涉人工智能纠纷案件的意见〉》: https://ipc.court.gov.cn/zh-cn/news/view-6036.html
  • 国家知识产权局《国务院关于印发〈知识产权保护和运用”十五五”规划〉的通知》(国发〔2026〕30号): https://www.cnipa.gov.cn/art/2026/7/31/art_3693_207456.html

人工智能相关发明创造的专利确权边界与商标使用证据要求(2026年9月)/ AI-Related Inventions and Trademark Evidence in China

概述

2026年9月对中国知识产权保护是一个值得关注的节点:行政与司法两个层面在同一年内就人工智能相关创造的边界作出呼应——既保护人的创造性,又为人工智能辅助的技术方案留出空间。自2026年1月1日施行的新版《专利审查指南》明确了谁可被列为发明人,以及如何判断专利保护客体。最高人民法院于2026年9月7日发布的《关于依法审理涉人工智能纠纷案件的意见》首次为法院提供专门规则——第14条,界定涉人工智能发明创造何时构成专利法所保护的客体。围绕这一核心,《知识产权保护和运用”十五五”规划》(国发〔2026〕30号)指明前瞻方向,新修订《专利优先审查管理办法》(局令第85号)自2026年9月1日起施行,商标使用证据标准在实践中持续收紧。对在华提交申请的外国申请人而言,综合信号很明确:保护并证明人的创造性,并保留能够证明这一点的文档痕迹。

行政审查:发明人必须是人

自2026年1月1日施行的新版《专利审查指南》正面回应人工智能问题。第一,发明人必须是自然人,请求书中不得填写人工智能系统作为发明人——”发明人”的法律地位专属于自然人,无论多先进的人工智能工具都只是人类发明人的器具。第二,指南确立”整体判断”原则:审查员将发明作为一个整体与法定要件衡量,而非孤立看待单一特征。这一点对人工智能相关申请尤为关键,其贡献可能体现在模型、算法或数据管线如何被应用于具体技术问题。申请人应将方案作为一体化技术整体呈现,而非对抽象思想或机器产出的简单主张,并确保列名发明人为可识别的自然人。

司法立场:最高人民法院2026年9月意见

2026年9月7日,最高人民法院发布《关于依法审理涉人工智能纠纷案件的意见》,是国家最高审判机关发布的首部涉人工智能司法裁判规则文件。其第三部分(第12至16条)专述知识产权纠纷,涵盖侵权责任认定、开源软件法律责任、专利授权确权、技术合同履行及数据使用规范。

第14条是与专利关系最直接的条款,明确:涉人工智能发明创造”采用遵循自然规律的技术手段,解决了技术问题,实现了符合自然规律的技术效果的”,依法认定为专利法所保护的客体。适用的仍是熟悉的三要素检验——技术手段、技术问题、技术效果——并应用于人工智能相关客体;意见同时明确,专利制度保护的是人的创造性,而非机器的产出。这使司法门槛与行政”整体判断”原则对齐,为法院提供稳定、公开的裁判规则,并弥合了审查员与法官在对待人工智能辅助发明上可能存在的分歧。

政策层与优先审查

《知识产权保护和运用”十五五”规划》(国发〔2026〕30号,2026年7月27日印发)提出”完善算法、人工智能生成物以及与平台经济发展相关的知识产权保护规则”,并承诺持续完善专利相关法律制度。它释放出信号:人工智能相关知识产权的规则仍在构建之中,走向是更清晰、更有针对性的保护,而非简单排斥。

新修订《专利优先审查管理办法》(局令第85号)自2026年9月1日起施行,取代2017年版,将快车道资源导向高价值申请——涉及新兴产业、未来产业或关键核心技术攻关,或省级、设区的市级人民政府重点鼓励产业等情形——并对违反诚信原则的行为设定罚则。2026年8月26日的实施工作通知明确衔接:自9月1日起提交的优先审查请求按新办法办理,此前已提交的按原办法办理;复审或无效宣告案件的优先审查请求通过”专利业务办理系统”的”专利事务服务”模块线上办理;自9月1日起适用新版《专利优先审查请求书》表格。

商标侧:使用证据与”连续三年不使用撤销”

商标领域,”连续三年不使用撤销”(”撤三”)程序的证据纪律收紧得最为明显。注册商标无正当理由连续三年未真实使用的,可经请求被撤销;审查如今更重视可采信的电子材料,强调形成可追溯、相互印证的完整链条:一份合同、对应订单、付款记录、物流凭证、平台在售页面与宣传记录应彼此印证。一张孤立发票已不足够;虚假交易发票、缺乏真实履行的形式化订单,或仅为制造”使用痕迹”而设的防御性挂靠安排,正被持续挤出。

这一方向得到新修订《商标法》的强化。该法于2026年6月26日通过,自2027年1月1日起施行,是1983年施行以来的首次全面修订。修订将诚实信用原则写入法律文本,收紧注册入口以遏制囤积与抢注,并强化对商标代理机构的监管。对境外品牌权利人而言,更严格的使用证据期待叠加诚信法定原则,意味着有据可查的真实商业使用,是维持商标存续、击退”撤三”请求最稳妥的方式。

申请人实务要点

人工智能相关专利申请:一是记录人的贡献——确保列名发明人为自然人,并保留谁主导、谁完成创造性工作的内部记录;二是围绕三要素撰写,将技术手段、问题与效果作为一体化方案阐明;三是留存研发与数据来源痕迹,记录训练数据的来源与授权;四是提前备妥审查意见答复材料,用检索报告与现有技术材料从整体上说明方案为何构成合法技术贡献。

商标保护:一是为核心商标建立使用证据档案,保存带日期的合同、订单、付款、物流、平台在售信息与宣传材料;二是以平台页面、海关记录等独立来源使证据链自我印证;三是将防御性注册与实际商业规划挂钩,明显超出正常经营需要的申请有驳回与恶意认定风险;四是提前备好撤销答辩材料,而非待”撤三”请求来临才着手。

相关阅读

  • 新版《专利审查指南》(2026年1月1日施行)关于发明人地位与客体判断的规定。
  • 最高人民法院《关于依法审理涉人工智能纠纷案件的意见》(2026年9月7日),第三部分专述知识产权纠纷。
  • 《知识产权保护和运用”十五五”规划》(国发〔2026〕30号)。
  • 新修订《专利优先审查管理办法》(局令第85号,2026年9月1日施行)。

来源

  • 国家知识产权局(官网):https://www.cnipa.gov.cn/
  • 林州市人民政府(新版《专利优先审查管理办法》全文转载):https://www.linzhou.gov.cn/2026/09-07/3658810.html
  • 浙江省市场监督管理局(浙江省知识产权局)《关于做好〈专利优先审查管理办法〉有关实施工作的通知》转载:https://zjamr.zj.gov.cn/col/col1229094027/art/2026/art_c86f0eda26b8439d806be9a748519f47.html
  • 最高人民法院(官网):https://www.court.gov.cn/
  • 最高人民法院知识产权法庭《以人为本 智能向善——聚焦〈最高人民法院关于依法审理涉人工智能纠纷案件的意见〉》:https://ipc.court.gov.cn/zh-cn/news/view-6036.html
  • 国家知识产权局《国务院关于印发〈知识产权保护和运用”十五五”规划〉的通知》(国发〔2026〕30号):https://www.cnipa.gov.cn/art/2026/7/31/art_3693_207456.html

China’s Foreign Investment Negative List in 2026: Sector Opening, Encouraged Catalogue and Market Access in Practice

  • China’s national foreign-investment negative list stands at 29 items and the free-trade-zone version at 27 items, with all manufacturing access restrictions eliminated — including the removal of the “publication printing must be Chinese-controlled” and “prohibition on Chinese medicine decoction-piece processing technology” limits.
    全国版外资准入负面清单为 29 条,自由贸易试验区版为 27 条,制造业领域外资准入限制措施已全部清零——包括取消”出版物印刷须由中方控股”与”禁止投资中药饮片炮制技术”等限制。
  • The 15th Five-Year Plan commits to expanding market access with services as the focus, promoting the orderly opening of telecom, internet, education, culture and healthcare, and piloting value-added telecom, biotechnology and wholly foreign-owned hospital regimes.
    “十五五”规划纲要以服务业为重点扩大市场准入,推动电信、互联网、教育、文化、医疗等领域有序扩大开放,稳妥实施增值电信、生物技术、外商独资医院等开放试点。
  • At the September 2026 NDRC roundtable with multinational firms, authorities signalled continued services opening, higher investment convenience, optimised cross-border data flows, the profit-reinvestment tax preference, and a push to make foreign firms both “admitted and operable” by clearing inconsistent local rules and unblocking post-access bottlenecks.
    在 2026 年 9 月国家发展改革委与跨国企业高层圆桌会上,主管部门释放持续扩大服务业开放、提升投资便利度、优化数据跨境流动、落实利润再投资税收优惠,并通过清理不符文件、打通准营堵点落实外资企业”准入又准营”的信号。
  • The negative list answers “can you enter”; the Catalogue of Encouraged Industries (2025 edition, NDRC and MOFCOM Order No. 37, effective 1 February 2026) answers “what support you get once in” — the two instruments are applied in combination, not in isolation.
    负面清单管”能不能进”,《鼓励外商投资产业目录(2025 年版)》(国家发展改革委、商务部第 37 号令,2026 年 2 月 1 日施行)管”进了有什么支持”,二者叠加使用而非各自孤立。
  • The binding constraint is shifting from access to operation permission: sector licences, product registration, government procurement and standards participation now do much of the screening, so pre-investment screening must pair the list check with a catalogue and a post-access bottleneck map.
    约束重心正从准入转向准营:行业许可、产品注册、政府采购与标准参与承担了大部分筛选,故投资前筛查须将清单核查与鼓励目录、准营堵点地图并列推进。
  • Practical steps: screen the business scope against the current list and the FTZ list, use standardised business-scope wording, distinguish filing from approval, and pre-empt post-access blockages in licensing, procurement and standards.
    实操步骤:将经营范围对照现行全国与自贸试验区清单,使用规范经营范围表述,区分备案制与核准制,并预先应对许可、政府采购、标准制定等准营堵点。

China’s Foreign Investment Negative List in 2026: Sector Opening, Encouraged Catalogue and Market Access in Practice | 2026 年中国外资准入负面清单:行业开放、鼓励目录与准入实操

Overview

The foreign-investment negative list is the gateway instrument of China’s market-access system: outside the listed items, foreign investors are treated on a par with domestic ones under the pre-establishment national-treatment-plus-negative-list regime. In 2026 the list is stable in length but active in meaning — 29 national items, 27 in the free-trade zones, manufacturing fully cleared — with the year’s policy energy directed at services and at the post-access journey where licences and standards do the screening. This article maps the list landscape, the 15th Five-Year Plan, the September 2026 NDRC roundtable signals, and how the list interacts with the Catalogue of Encouraged Industries (2025 edition), then sets out a screening method and common post-access bottlenecks.

The current negative-list landscape

The operative national negative list is the 2024 edition (NDRC and MOFCOM Order No. 23), in force since 1 November 2024, with 29 items — the shortest in the instrument’s history. Through 2026 no new national edition has been published. The free-trade-zone negative list stands at 27 items. Manufacturing access restrictions have been fully “zeroed out”: compared with the 2021 edition, the 2024 national list deleted the last two manufacturing limits — “publication printing must be Chinese-controlled” and “prohibition on investment in the application of Chinese medicine decoction-piece processing techniques such as steaming, frying, roasting and calcining, and in the production of products with confidential traditional Chinese medicine prescriptions” — leaving manufacturing without foreign-access restrictions.

What remains concentrates on a narrow set of security- and sensitivity-related sectors: news and publishing, culture, education, telecom, mining and agricultural breeding. Strategically, the list is now a stable floor; the next movement is expected in services, via pilots and mechanism-building rather than a single full revision.

The 15th Five-Year Plan deployment

The 15th Five-Year Plan outline frames the opening agenda. It commits to expanding market access with services as the priority and opening more fields, attracting foreign investment. It names telecom, internet, education, culture and healthcare as the sectors for orderly further opening, and it tasks the authorities with piloting value-added telecom, biotechnology and wholly foreign-owned hospital regimes, while advancing comprehensive pilots and demonstrations of services-sector opening. The plan’s logic is that, with manufacturing largely open, the marginal liberalisation that matters to foreign investors sits in services and in the operating environment after entry.

The September 2026 NDRC roundtable: the post-access signal

On 10–11 September 2026, the NDRC held a high-level roundtable with multinational firms in Beijing under the theme of embracing the 15th Five-Year Plan. The signals most relevant to market access were concrete and forward-looking.

On opening: officials stated that during the 15th Five-Year Plan period, on the basis of fully assessing existing pilots, China will continue to promote the orderly opening of telecom, internet, education, culture and healthcare, and prudently implement pilots in value-added telecom, biotechnology and wholly foreign-owned hospitals; it will steadily expand financial-market connectivity, optimise the qualified foreign-investor regime and broaden investable products, and orderly advance eligible enterprises’ cross-border two-way direct financing.

On the business environment: officials pledged to further raise the convenience of foreign investment, optimise cross-border data-flow management, and implement the tax preference for overseas investors’ direct investment with distributed profits. On the core post-access agenda, the NDRC’s foreign-investment department stated that a key task is to deliver foreign firms being “both admitted and operable” — supervising local governments to continuously clear documents and rules inconsistent with the Foreign Investment Law, unblocking the bottlenecks that foreign firms hit after admission, and prudently advancing value-added-telecom, biotechnology and foreign-invested-hospital pilots in relevant localities. It also committed to introducing optimisation measures and fully implementing national treatment for foreign firms.

The takeaway for investors is that the 2026 agenda is less about shrinking the list’s item count and more about making the remaining items operable, and about removing the local rules and licensing frictions that sit behind the list.

Negative list meets encouraged catalogue: a combined method

The negative list and the Catalogue of Encouraged Industries answer different questions. The negative list sets the ceiling — what is prohibited or capped. The Catalogue of Encouraged Industries (2025 edition, NDRC and MOFCOM Order No. 37, effective 1 February 2026) sets the floor of support — what is encouraged and what benefits follow. The 2025 catalogue has 1,679 entries in total: a national catalogue of 619 entries and a regional catalogue of 1,060 entries for central-west, northeast and Hainan, guiding foreign investment into advanced manufacturing, modern services, high-tech, energy conservation and environmental protection, and into central-west and northeast regions.

The method applies the two in combination. Step one: confirm the target sector is not on the negative list (or, if capped, design a compliant ownership structure). Step two: check whether the sector or a sub-item appears in the encouraged catalogue — if so, the project may qualify for import, land and tax support at national and local levels. Step three: note that encouragement does not override the list — a sector can be both encouraged and, in a specific sub-activity, still restricted, so the two must be read together. The Action Plan for Stabilising and Optimizing Foreign Investment (Shangzi Fa [2026] No. 97) is the operational bridge: it opens services pilots and steers support to encouraged activities, so the list, the catalogue and the action plan should be consulted together.

Pre-investment screening in practice

  1. Screen the business scope against the list. Map the proposed activity to the 29-item national list and, if entering a pilot zone, to the 27-item FTZ list; confirm whether the activity is prohibited, capped (e.g., equity ratio) or free.
  2. Use standardised business-scope wording. Register the business scope with the standardised expressions from the national business-scope registration system; vague or non-standard wording is a frequent cause of downstream licensing friction.
  3. Distinguish filing from approval. Most post-access items are record-filing (备案); a smaller set requires administrative approval (核准) or a sector licence. Identify which applies before committing capital, because approval items carry a harder gate than filing.
  4. Read the encouraged catalogue in parallel. Check the national and regional catalogues for the sector; if present, build the incentive case (imports, land, tax) into the investment model from day one.
  5. Draw a post-access bottleneck map. List the licences, product registrations, procurement qualifications and standards bodies the venture will need, and assess each as a gate before signing.

Common post-access bottlenecks and responses

The “admitted but not operable” problem recurs in three places. First, licensing: a cleared entry still needs the sector licence (medical, telecom or education), with its own timetable — start it with incorporation. Second, government procurement and subsidies: eligibility often turns on domestic standards, local presence and compliance records; assemble evidence early. Third, standards: the ability to sell may depend on conformity with mandatory and recommended standards and on a voice in standard-setting; track the technical committees and conformity pathways.

Treat the negative list as the first checkbox, not the last. Pair it with the encouraged catalogue for support and with a candid post-access map for execution.

Sources

  • 中国政府网《中国”十五五”规划,为世界提供新机遇》: https://www.gov.cn/yaowen/liebiao/202609/content_7081427.htm
  • 中国政府网 政策解读《2024 年版全国外资准入负面清单发布 制造业领域外资准入限制措施”清零”》(29 条、制造业清零、出版物印刷与中药饮片条目取消): https://www.gov.cn/zhengce/202409/content_6973149.htm
  • 国家发展改革委 答记者问《外商投资准入特别管理措施(负面清单)(2024 年版)》(全国版 29 条、自贸试验区版 27 条、制造业清零): https://www.ndrc.gov.cn/xxgk/jd/jd/202409/t20240907_1392877.html
  • 国家发展改革委《鼓励外商投资产业目录(2025 年版)》解读(第 37 号令,2026 年 2 月 1 日施行,总条目 1679 条): https://www.ndrc.gov.cn/xxgk/jd/jd/202512/t20251224_1402574.html
  • 中国新闻网《苹果、霍尼韦尔、康宁等在华美企面对面提问国家发改委》(2026 年 9 月圆桌会、”准入又准营”、清理不符文件、打通准营堵点): https://www.chinanews.com.cn/cj/2026/09-10/10694229.shtml
  • 商务部《利用外资固稳促优行动方案》(商资发〔2026〕97 号): https://www.mofcom.gov.cn/zcfb/wgtzgl/art/2026/art_0cfe31a63f9c4bd3869517bc10908c10.html
  • 国家发展改革委: https://www.ndrc.gov.cn/
  • 商务部: https://www.mofcom.gov.cn/

2026 年中国外资准入负面清单:行业开放、鼓励目录与准入实操

概述

外资准入负面清单是中国市场准入体系的闸口工具:清单之外,外国投资者在准入前国民待遇加负面清单管理体制下与内资一视同仁。2026 年清单篇幅稳定但意涵活跃——全国版 29 条、自贸试验区版 27 条、制造业限制全部清零,政策能量投向”准入到准营”这段由行业许可与标准承担实质筛选的旅程。本文勾勒现行清单格局、”十五五”部署、2026 年 9 月发改委圆桌会信号,并说明负面清单如何与《鼓励外商投资产业目录(2025 年版)》衔接,最后给出投资前筛查方法与常见准营堵点。

现行负面清单格局

现行有效的全国版清单是 2024 年版(国家发展改革委、商务部第 23 号令),自 2024 年 11 月 1 日起施行,共 29 条——为制度设立以来最短版本。2026 年全年尚未发布新版全国清单。自由贸易试验区版清单为 27 条。制造业准入限制已全面”清零”:相比 2021 年版,2024 年全国版删除了制造业仅剩的两条限制——”出版物印刷须由中方控股”与”禁止投资中药饮片的蒸、炒、炙、煅等炮制技术的应用及中成药保密处方产品的生产”——制造业已无外资准入限制。

清单剩余条目集中于少数安全与敏感领域:新闻出版、文化、教育、电信、采矿、农业育种等。战略上清单已成”稳定的地板”,下一步动作预计出现在服务业,通过试点与机制建设推进,而非一次全盘修订。

“十五五”规划部署

“十五五”规划纲要框定了开放议程。它以服务业为重点扩大市场准入、拓展开放领域,吸引外资;点名电信、互联网、教育、文化、医疗为有序扩大开放的领域,并部署稳妥实施增值电信、生物技术、外商独资医院等开放试点,推进服务业扩大开放综合试点示范。其逻辑是:制造业基本放开后,对外国投资者真正重要的边际开放落在服务业与进入后的经营环境。

2026 年 9 月发改委圆桌会:准营端信号

2026 年 9 月 10 日至 11 日,国家发展改革委以”拥抱’十五五'”为主题在北京召开与跨国企业高层圆桌会。与准入最相关的信号具体且前瞻。

开放方面:有关负责人表示,”十五五”时期将在充分评估现有试点基础上,持续推动电信、互联网、教育、文化、医疗等领域有序扩大开放,稳妥实施增值电信、生物技术、外商独资医院等开放试点;稳慎拓展金融市场互联互通,优化合格境外投资者制度、扩大可投资品种范围,有序推进符合条件的企业跨境双向直接融资。

营商环境方面:将进一步提升外商投资便利度、优化数据跨境流动管理、落实境外投资者以分配利润直接投资税收优惠政策。在准营核心议程上,国家发展改革委外资司表示,外资领域一项重点工作就是落实好外资企业”准入又准营”——督导各地持续清理与外商投资法不符的文件法规,打通外资企业准营的堵点卡点,同时稳妥推动有关地方开展增值电信、生物技术、外商投资医院等试点,并推动出台优化措施、全面落实外资企业国民待遇。

对投资者的要义是:2026 年议程的重点不在于压缩清单条数,而在于让剩余条目”可运营”,并清除清单背后的地方文件与许可摩擦。

负面清单衔接鼓励目录:叠加方法

负面清单与鼓励目录回答不同问题。负面清单设定上限——什么禁止或受限;鼓励目录(2025 年版,国家发展改革委、商务部第 37 号令,2026 年 2 月 1 日施行)设定支持的底线——什么受鼓励、进入后享有什么利好。2025 年版鼓励目录共 1679 条:全国目录 619 条,中西部等地区外商投资优势产业目录 1060 条,引导外资投向先进制造业、现代服务业、高新技术、节能环保及中西部、东北地区。

方法是二者叠加使用。第一步:确认目标行业不在负面清单上(若受限,则设计合规的股权结构)。第二步:核查该行业或其具体条目是否出现在鼓励目录——若在,项目可适用进口、用地、税收等支持政策。第三步:注意鼓励不凌驾于限制,某一行业可同时”受鼓励”又在某项具体活动上”仍受限”,故二者须对照阅读,不能假定互斥。《利用外资固稳促优行动方案》(商务部、国家发展改革委、财政部印发,商资发〔2026〕97 号,经国务院同意)是操作桥梁:既开放服务业试点,又将支持导向鼓励类活动,故清单、目录与行动方案应一并查阅。

投资前筛查实操

  1. 对照清单筛查经营范围。将拟议活动映射到 29 条全国版清单;进入试点区域的,再对照 27 条自贸试验区版;确认属于禁止、受限(如股比)或自由。
  2. 使用规范经营范围表述。通过全国统一经营范围规范表述系统登记经营范围;表述模糊或非标准,是下游许可摩擦的常见诱因。
  3. 区分备案制与核准制。多数准营事项为备案;少数须行政审批或行业许可。注资前识别适用类别,因核准事项门槛硬于备案。
  4. 并行查阅鼓励目录。核查全国与地区目录是否含该行业;若含,自第一天起将进口、用地、税收等激励纳入投资模型。
  5. 绘制准营堵点地图。列出企业将需要的许可、产品注册、采购资质与标准机构,在签约前将每一项评估为关卡。

常见准营堵点与应对

“准入不准营”集中出现在三处。其一,许可:清单已放行的项目仍需行业许可(如医疗、电信、教育牌照),且许可申请自有时间表与实质要求——应与设立并行启动。其二,政府采购与补贴:资格常取决于是否符合国内标准、本地存在与合规记录,尽早备齐证据包。其三,标准参与:能否销售可能取决于是否符合强制性与推荐性标准、能否参与标准制定,跟踪相关技术委员会与合格评定路径。

建设性姿态是把负面清单当作第一个勾选项而非最后一个,与鼓励目录搭配获支持、与准营地图搭配落地执行。2026 年 9 月信号表明,通过外资企业圆桌会与一站式窗口提出准营堵点问题,是被认可的渠道。

来源

  • 中国政府网《中国”十五五”规划,为世界提供新机遇》:https://www.gov.cn/yaowen/liebiao/202609/content_7081427.htm
  • 中国政府网 政策解读《2024 年版全国外资准入负面清单发布 制造业领域外资准入限制措施”清零”》(29 条、制造业清零、出版物印刷与中药饮片条目取消):https://www.gov.cn/zhengce/202409/content_6973149.htm
  • 国家发展改革委 答记者问《外商投资准入特别管理措施(负面清单)(2024 年版)》(全国版 29 条、自贸试验区版 27 条、制造业清零):https://www.ndrc.gov.cn/xxgk/jd/jd/202409/t20240907_1392877.html
  • 国家发展改革委《鼓励外商投资产业目录(2025 年版)》解读(第 37 号令,2026 年 2 月 1 日施行,总条目 1679 条):https://www.ndrc.gov.cn/xxgk/jd/jd/202512/t20251224_1402574.html
  • 中国新闻网《苹果、霍尼韦尔、康宁等在华美企面对面提问国家发改委》(2026 年 9 月圆桌会、”准入又准营”、清理不符文件、打通准营堵点):https://www.chinanews.com.cn/cj/2026/09-10/10694229.shtml
  • 商务部《利用外资固稳促优行动方案》(商资发〔2026〕97 号):https://www.mofcom.gov.cn/zcfb/wgtzgl/art/2026/art_0cfe31a63f9c4bd3869517bc10908c10.html
  • 国家发展改革委:https://www.ndrc.gov.cn/
  • 商务部:https://www.mofcom.gov.cn/

Foreign Investment Security Review in China: September 2026 Filing Practice and Local Support Mechanisms

  • On 14 September 2026, the China (Hebei) Pilot Free Trade Zone Zhengding Area released a Filing Guide for Foreign-Investment Security Review that establishes a four-tier process: enterprise filing, zone service, hierarchical verification, and national final review.
    2026 年 9 月 14 日,中国(河北)自由贸易试验区正定片区发布《外商投资安全审查申报指引》,确立”企业申报、片区服务、逐级核验、国家终审”四级流程。
  • The guide creates a “foreign-investment security-review service officer” system and a dedicated “security-review service window” (co-located with the foreign-investor complaint office); the investment-service bureau gives a preliminary assessment feedback within five working days of receiving an enquiry or initial materials.
    指引建立”外商投资安全审查服务官”制度与”安全审查服务专窗”(与外商投诉服务办公室合署);投资服务局在收到咨询或初步材料后 5 个工作日内给予初步研判反馈。
  • The filing basis is the Foreign Investment Law and its implementing regulations, together with the Security Review Measures (NDRC & MOFCOM Order No. 37 of 2020). This article covers the service mechanism and recent practice, not the thresholds and timelines already detailed in the site’s general security-review guide.
    申报依据为《外商投资法》及其实施条例,以及《外商投资安全审查办法》(国家发展改革委、商务部令 2020 年第 37 号)。本文聚焦申报服务机制与近期实操口径,不重复站内安全审查总论已详述的门槛与时限。
  • A publicly documented case — the 27 April 2026 prohibition decision by the foreign-investment security-review working mechanism office (housed at the NDRC) on the foreign acquisition of the Manus project — illustrates the review’s scope and the “substance-over-form” piercing principle.
    一例公开案件——2026 年 4 月 27 日外商投资安全审查工作机制办公室(设在国家发展改革委)就外资收购 Manus 项目作出的禁止投资决定——体现了审查范围与”实质重于形式”的穿透原则。
  • Outcomes fall into three categories — approval, approval with conditions, or prohibition — and non-compliance can lead to orders to divest equity or assets, restoration of the pre-investment state, and adverse credit records.
    审查结论分三类——通过、附条件通过、禁止投资——违规可能导致限期处分股权或资产、恢复投资前状态及不良信用记录。
  • Practical readiness means using pre-filing consultation, preparing materials early, leveraging local coaching and pre-review, embedding conditions precedent in deal documents, and budgeting realistic timeline expectations.
    实操准备意味着善用申报前咨询、尽早备齐材料、借力地方辅导与预审、在交易文件中嵌入先决条件,并对时间轴作出务实预期。

Foreign Investment Security Review in China: September 2026 Filing Practice and Local Support Mechanisms | 中国外商投资安全审查:2026 年 9 月申报实操与地方服务机制

Overview

China’s foreign-investment security review is the gate that no sizeable inbound transaction can structure around. The operative rules — the Security Review Measures (NDRC & MOFCOM Order No. 37 of 2020, effective January 2021) — set the reporting scope, the two-stage review timeline and the three possible outcomes. Those structural elements are set out in our general security-review guide and are not repeated here.

This article instead focuses on two developments from 2026 that change how foreign investors actually experience the filing: a concrete local filing-support mechanism published by the Zhengding pilot zone in September 2026, and a publicly documented prohibition decision that clarifies the review’s reach. The emphasis throughout is practical — how to engage the system efficiently and what to build into a transaction’s documentation.

The Zhengding pilot-zone filing guide (14 September 2026)

On 14 September 2026, the Management Committee of the China (Hebei) Pilot Free Trade Zone Zhengding Area published the *Filing Guide for Foreign-Investment Security Review in the Zhengding Area*. The guide’s stated purpose is to implement the Foreign Investment Law and its implementing regulations and the Security Review Measures, to standardise security-review filing within the zone, and to facilitate enterprises’ compliant filing while preventing and resolving national-security risks in the foreign-investment field.

Basis and scope. The guide cites as its basis: the Foreign Investment Law and its implementing regulations; the Security Review Measures (NDRC & MOFCOM Order No. 37); the Overall Plan for the China (Hebei) Pilot Free Trade Zone and related strategic upgrading documents; and the zone’s own implementation plans for aligning with international high-standard economic and trade rules and strengthening the security-review mechanism. It applies to foreign investors and relevant domestic parties within the zone whose investment falls within the scope of the Security Review Measures and requires filing with the national security-review working-mechanism office.

The four-tier principle. The guide organises the review work around the principle of “enterprise filing, zone service, hierarchical verification, and national final review.” The first two tiers are described in operational detail:

  1. *Zone coaching and pre-review.* The zone’s Investment Service Bureau acts as the lead service department. It establishes a “foreign-investment security-review service officer” system to provide guidance to key enterprises, and sets up a dedicated “security-review service window” (co-located with the zone’s foreign-investor complaint office) offering policy consultation, materials pre-review and process guidance as a one-stop service. Upon receiving an enterprise’s enquiry or initial materials, the Investment Service Bureau gives a preliminary assessment feedback within five working days and coaches the enterprise to complete its filing materials.
  2. *Municipal preliminary compliance verification.* The enterprise submits the complete filing materials to the municipal-level competent departments — the Shijiazhuang Development and Reform Commission and the Municipal Commerce Bureau. Those departments perform a preliminary compliance verification of the completeness and standardisation of the materials.

The upper tiers — hierarchical verification and national final review — follow the working-mechanism office’s statutory process under Order No. 37. The guide’s contribution is to make the local front-end service explicit and time-bound, so that enterprises in the zone have a named contact and a defined feedback clock before materials reach the national office.

A documented prohibition decision: the Manus project

The reach of the security review is illustrated by a publicly documented case. On 27 April 2026, the foreign-investment security-review working-mechanism office (housed at the National Development and Reform Commission) issued, in accordance with laws and regulations, a decision prohibiting foreign investment in the acquisition of the Manus project and ordered the parties to revoke the acquisition transaction. The decision was published on the NDRC government-information-disclosure page.

Two points from this case are relevant to transaction planning. First, the review scope explicitly covers important information-technology and internet products and services, as well as key technologies — sectors that frequently sit at the centre of cross-border technology and AI deals. Second, the case reflects the “substance-over-form” piercing principle: a transaction structured so that the underlying assets, technology or data originate within China may still fall within the review’s jurisdiction regardless of where the entities are incorporated. The working-mechanism office’s decision is a final decision under the Foreign Investment Law, and the three possible outcomes of any review are approval, approval with conditions, or prohibition.

This article states the case as a matter of public record and does not attach any value judgement to the parties or the commercial context. The point for practitioners is operational: the security-review gate applies to sensitive-sector control transactions wherever they are booked, and the piercing principle means entity location is not a reliable shield.

Practical filing playbook

1. Use pre-filing consultation early. The Security Review Measures expressly permit parties to consult the working-mechanism office before filing. For borderline transactions, this consultation should happen during structuring, not after a term sheet is signed.

2. Prepare the core materials. A filing requires a filing statement, an investment plan, a statement on whether the investment affects national security, and any other materials the office prescribes. The filing statement should set out the foreign investor’s name, domicile, business scope and the basic facts of the investment. Build the national-security-impact statement during due diligence, not at closing.

3. Leverage local coaching and pre-review. Where a zone such as Zhengding offers a service-officer system and a dedicated window with a five-working-day feedback clock, use it to de-risk the materials before they reach the municipal and national levels. Local pre-review reduces the risk of a defective filing that triggers delays.

4. Budget the timeline realistically. Under Order No. 37, the office decides within 15 working days whether a review is needed; a general review completes within 30 working days; a special review within 60 working days (extendable in exceptional cases). The investment may not be implemented during the review. Treat these as hard clocks when sequencing a deal.

5. Embed conditions precedent in deal documents. Where a sector is sensitive but potentially approvable, anticipate conditional approval and embed the necessary regulatory filings — including the security review — as conditions precedent to closing, with clear long-stop dates and termination rights.

6. Respect the consequences of non-compliance. Failing to file an in-scope investment, providing false materials, or breaching attached conditions can lead to orders to file, to divest equity or assets, to restore the pre-investment state, and to recording in the national credit-information system with joint disciplinary measures. These outcomes are enforceable and should be reflected in the deal’s risk allocation.

Related reading

  • Our general security-review guide, which details the reporting scope, the control definition, the statutory timeline and the outcomes.
  • The Security Review Measures (NDRC & MOFCOM Order No. 37 of 2020), the operative regulation.
  • The Foreign Investment Law (2020), which establishes the security review at law level.

Sources

  • 中国(河北)自由贸易试验区正定片区管理委员会《正定片区外商投资安全审查申报指引》(2026-09-14):http://www.sjzzhbsq.gov.cn/columns/dc61a0a4-dd22-4dbc-a012-78b211e02b06/202609/14/d703655c-31b8-4189-ad9b-8e545f1cf4f0.html
  • 国家发展改革委政府信息公开《外商投资安全审查工作机制办公室(国家发展改革委)对外资收购 Manus 项目作出安全审查决定》(2026-04-27):https://zfxxgk.ndrc.gov.cn/web/iteminfo.jsp?from=qcc&id=20623
  • 国家发展改革委:https://www.ndrc.gov.cn/
  • 中国政府网《外商投资安全审查办法》(国务院公报):https://big5.www.gov.cn/gate/big5/www.gov.cn/gongbao/content/2021/content_5582626.htm
  • 商务部《外商投资安全审查办法》(国家发展改革委、商务部令第 37 号原文):https://www.mofcom.gov.cn/dl/file/20211203230801.pdf

中国外商投资安全审查:2026 年 9 月申报实操与地方服务机制

概述

中国外商投资安全审查是任何规模化入境交易都无法绕开的闸门。现行操作规则——《外商投资安全审查办法》(国家发展改革委、商务部令 2020 年第 37 号,2021 年 1 月施行)——界定了申报范围、两阶段审查时限与三类审查结论。这些结构性要素已在本站点安全审查总论中详述,此处不再重复。

本文转而聚焦 2026 年改变外资实际申报体验的两项进展:正定片区于 2026 年 9 月发布的具体地方申报服务机制,以及一例厘清审查辐射范围的公开禁止投资决定。全文贯穿实操导向——如何高效对接制度,以及应在交易文件中嵌入什么。

正定片区申报指引(2026 年 9 月 14 日)

2026 年 9 月 14 日,中国(河北)自由贸易试验区正定片区管理委员会发布《正定片区外商投资安全审查申报指引》。指引载明的目的,是落实《外商投资法》及其实施条例与《外商投资安全审查办法》,规范片区内外商投资安全审查申报工作,便利和服务片区内外商投资企业依法依规办理安全审查申报,切实防范化解外商投资领域国家安全风险。

依据与范围。 指引列明的制定依据包括:《中华人民共和国外商投资法》及其实施条例;《外商投资安全审查办法》(国家发展改革委、商务部令第 37 号);《中国(河北)自由贸易试验区总体方案》及相关战略提升文件;正定片区关于对接国际高标准经贸规则、强化安全审查机制的相关实施方案。指引适用于片区内投资行为属于《外商投资安全审查办法》规定范围、需向国家外商投资安全审查工作机制办公室申报安全审查的外国投资者及境内相关主体。

四级原则。 指引围绕”企业申报、片区服务、逐级核验、国家终审”的原则组织审查工作,并对前两级作出操作层面的细致描述:

  1. 片区辅导与预审。 正定片区投资服务局作为牵头服务部门,建立”外商投资安全审查服务官”制度,为重点企业提供指导服务;设立”安全审查服务专窗”(与正定片区外商投诉服务办公室合署办公),提供政策咨询、材料预审、流程指引等”一站式”服务。投资服务局在收到企业咨询或初步材料后,5 个工作日内给予初步研判反馈,辅导企业完善申报材料。
  2. 市级初步合规核验。 企业将完备的申报材料提交至石家庄市发展改革委、市商务局等市级主管部门。市级主管部门负责对申报材料的完整性、规范性进行初步合规核验。

更上级的逐级核验与国家终审,依第 37 号令下工作机制办公室的法定程序推进。指引的贡献在于,将地方前端服务明确化、时限化,使片区企业在材料送达国家办公室之前,即有具名对接人与明确的反馈时钟。

一例公开的禁止投资决定:Manus 项目

审查的辐射范围可由一例公开案件说明。2026 年 4 月 27 日,外商投资安全审查工作机制办公室(设在国家发展改革委)依法依规对外资收购 Manus 项目作出禁止投资决定,要求当事人撤销该收购交易。该决定已在国家发展改革委政府信息公开页发布。

本案有两点与交易规划相关。其一,审查范围明确覆盖重要信息技术和互联网产品与服务,以及关键技术——这类领域常处于跨境科技与人工智能交易的核心。其二,本案体现”实质重于形式”的穿透原则:一项交易即便实体注册在境外,只要其底层资产、技术或数据源自中国境内,仍可能落入审查管辖。工作机制办公室的决定依《外商投资法》为最终决定,任何审查的结论均为三类之一:通过、附条件通过、禁止投资。

本文仅将本案作为公开记录陈述,不对当事人或商业背景作任何价值判断。对实务者的操作意义在于:安全审查闸门适用于敏感行业控制权交易,无论交易在何处记账;穿透原则意味着注册地并非可靠的规避屏障。

申报实操手册

1. 尽早善用申报前咨询。 《外商投资安全审查办法》明确允许当事人在申报前就有关问题向工作机制办公室咨询。对边界交易,咨询应在结构设计阶段进行,而非签署条款清单之后。

2. 备齐核心材料。 申报须提交申报书、投资方案、外商投资是否影响国家安全的说明,以及工作机制办公室规定的其他材料。申报书应载明外国投资者的名称、住所、经营范围与投资基本情况。国家安全影响说明应在尽调期间起草,而非交割阶段补做。

3. 借力地方辅导与预审。 在设有服务官制度与具名专窗(如正定片区 5 个工作日反馈时钟)的片区,应善用其于材料送达市、国家层级前完成风险前置化解。地方预审可降低因材料瑕疵引发延误的风险。

4. 对时间轴作出务实预期。 依第 37 号令,办公室自收到完备材料起 15 个工作日内决定是否需审查;一般审查 30 个工作日内完成;特别审查 60 个工作日内完成(特殊情况可延长)。审查期间不得实施投资。安排交易顺序时,应将上述时限视为硬性时钟。

5. 在交易文件中嵌入先决条件。 对敏感但可能获批的行业,预判附条件通过,将包括安全审查在内的必要监管申报设为交割先决条件,并设定明确的截止日期与终止权。

6. 尊重违规后果。 属于申报范围而未申报、提供虚假材料或违反附加条件,可能导致责令限期申报、限期处分股权或资产、恢复投资前状态,并记入国家信用信息系统实施联合惩戒。这些后果可强制执行,应在交易的风险分配中予以体现。

相关阅读

  • 本站点安全审查总论,详述申报范围、控制权定义、法定时限与审查结论。
  • 《外商投资安全审查办法》(国家发展改革委、商务部令 2020 年第 37 号),现行操作规章。
  • 《外商投资法》(2020 年),在法律层面确立安全审查制度。

来源

  • 中国(河北)自由贸易试验区正定片区管理委员会《正定片区外商投资安全审查申报指引》(2026-09-14):http://www.sjzzhbsq.gov.cn/columns/dc61a0a4-dd22-4dbc-a012-78b211e02b06/202609/14/d703655c-31b8-4189-ad9b-8e545f1cf4f0.html
  • 国家发展改革委政府信息公开《外商投资安全审查工作机制办公室(国家发展改革委)对外资收购 Manus 项目作出安全审查决定》(2026-04-27):https://zfxxgk.ndrc.gov.cn/web/iteminfo.jsp?from=qcc&id=20623
  • 国家发展改革委:https://www.ndrc.gov.cn/
  • 中国政府网《外商投资安全审查办法》(国务院公报):https://big5.www.gov.cn/gate/big5/www.gov.cn/gongbao/content/2021/content_5582626.htm
  • 商务部《外商投资安全审查办法》(国家发展改革委、商务部令第 37 号原文):https://www.mofcom.gov.cn/dl/file/20211203230801.pdf

Foreign M&A Rules in China: The 2026 Update and What It Means for Inbound Deals

  • China’s 2026 foreign-investment agenda puts foreign M&A management at the centre: the Action Plan (Shang Zi Fa [2026] No. 97) commits to revising the rules on foreign investors’ acquisition of domestic enterprises, streamlining the M&A process and consideration-payment requirements, and strengthening cross-departmental coordination.
    2026 年外资议程将外资并购管理置于核心:《利用外资固稳促优行动方案》(商资发〔2026〕97号)承诺修订外国投资者并购境内企业规定、优化并购流程与对价支付要求、强化部门协同。
  • At the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen on 7 September 2026, MOFCOM’s Department of Foreign Investment delivered a systematic reading of the “bring in” and “go global” policies, while the Investment Promotion Agency outlined overseas service platforms and overseas industrial parks as promotion mechanisms.
    2026 年 9 月 7 日厦门第 26 届投洽会上,商务部外资司系统解读”引进来””走出去”政策,商务部投资促进事务局介绍出海服务平台与境外产业园等促进机制。
  • The 15th Five-Year Plan explicitly deploys “improving foreign M&A management and widening the channels for foreign capital to invest in the securities market,” embedding the M&A easing into the五年规划 framework.
    “十五五”规划明确部署”完善外资并购管理,拓宽外资投资证券市场渠道”,将并购便利化写入五年规划框架。
  • Every inbound deal should run three compliance screens in parallel — the negative-list admission test, the merger-control (concentration) filing, and the foreign-investment security review — rather than treating them as sequential steps.
    每笔入境交易应并行推进三重合规核查——负面清单准入、经营者集中申报、外商投资安全审查——而非视为先后步骤。
  • Practical readiness now centres on the due-diligence checklist, consideration-and-payment arrangements, deal-structure design and approval-timeline management, because the current 10-Order rules still govern deals signed before the revision is published.
    实操准备当下聚焦于尽调清单、对价支付安排、交易结构设计与审批时间轴预期管理,因为现行 10 号令规则仍约束修订版出台前签署的交易。
  • Services opening to Hong Kong and Macao under CEPA is being advanced first, giving the two special administrative regions a front-running role in the two-way cross-border investment corridor.
    内地与香港、澳门 CEPA 服务业率先开放正加快推进,使港澳在双向跨境投资通道中扮演先行角色。

Foreign M&A Rules in China: The 2026 Update and What It Means for Inbound Deals | 中国外资并购规则:2026 年更新与对入境交易的影响

Overview

Foreign M&A has re-emerged as a priority instrument of China’s inbound-investment strategy in 2026. After a cycle dominated by negative-list cuts and the full removal of manufacturing access restrictions, the policy centre of gravity is shifting from “what is open” to “how smoothly capital can enter, combine and grow.” Three developments in 2026 give foreign acquirers a clearer map than at any point in the past two years: a concrete Action Plan commitment to revise the foreign-M&A rulebook, a high-visibility policy briefing at the September CIFIT in Xiamen, and a formal 15th Five-Year Plan deployment to improve M&A management and widen securities-market access for foreign capital.

This article focuses on the September 2026 dynamics and the practical deal-execution steps, pointing to companion pieces for the Action Plan text and the security-review filing details.

The September 2026 policy moment: CIFIT in Xiamen

The 26th China International Fair for Investment and Trade (CIFIT) was held in Xiamen, Fujian, from 8 to 11 September 2026. On 7 September, ahead of the main fair, the “Gateway to the World, Linking the Globe” two-way cross-border investment exchange and promotion session — a “Invest in China” themed side event — took place in Xiamen, hosted by MOFCOM and organised by the Investment Promotion Agency of MOFCOM and the Xiamen Municipal Commerce Bureau.

Two messages from that session matter for foreign M&A. First, MOFCOM’s Department of Foreign Investment gave a systematic interpretation of the “bring in” and “go global” policies. On the “bring in” side, it reaffirmed the measures taken since 2025 to optimise the foreign-investment environment, including the June 2026 Action Plan and the upgrade of the Closer Economic Partnership Arrangement (CEPA) with Hong Kong and Macao to open the services sector to them first. On the “go global” side, it noted steady growth in outward investment and deeper mainland–Hong Kong cooperation.

Second, the Investment Promotion Agency outlined how it serves enterprises on both fronts: using the CIFIT national-level platform, relying on overseas industrial parks and other outbound-promotion mechanisms, and jointly building an outbound-service platform with leading clusters such as the Hong Kong International Business Hub in Shanghai, Suzhou Industrial Park and the Jimei district of Xiamen. The agency links Hong Kong’s financial, legal and professional-service strengths with the mainland’s projects, parks and enterprise resources, so that more foreign capital enters the mainland through Hong Kong and more mainland enterprises go global with Hong Kong’s support.

For foreign acquirers, the practical read is that the September 2026 policy narrative is explicitly two-way: inbound M&A is being eased and facilitated at the same time as outbound investment is being serviced through structured platforms.

The 15th Five-Year Plan deployment

The 15th Five-Year Plan, the first such plan of the 2026–2030 period, contains a dedicated passage on attracting and utilising foreign capital. Among its measures, it states the intent to “expand the ways of using foreign capital, improve foreign M&A management, and widen the channels for foreign capital to invest in the securities market.” It also calls for high-quality implementation of the foreign-investment security review and improvement of the full-calibre external-debt supervision system.

This language elevates foreign M&A from a transactional sub-topic to a plan-level commitment, pairs M&A management with securities-market access as a unified equity-investment channel, and — by placing the security review in the same paragraph — makes explicit that facilitation and gatekeeping advance together.

The Action Plan anchor for M&A modernisation

The Action Plan for Stabilising and Optimising Foreign Investment Utilisation (Shang Zi Fa [2026] No. 97), issued by MOFCOM, the NDRC and the Ministry of Finance with State Council approval on 16 June 2026, is the operative anchor for the M&A changes. Its M&A-relevant commitments are specific: accelerate the revision and promulgation of the rules on foreign investors’ acquisition of domestic enterprises, optimising the M&A management process and consideration-payment requirements; strengthen cross-departmental regulatory coordination on foreign M&A; and allow eligible foreign equity-investment institutions to participate, as strategic investors, in securities issuance by listed companies in industries unrelated to their own.

The first two commitments speak to the long-awaited revision of the 2006 Measures on M&A of Domestic Enterprises (the “10-Order”). The core frictions are well understood: obsolete ex-ante approval clauses that no longer apply after the Foreign Investment Law took effect in 2020, consideration and payment rules that need to operate without an approval gateway, and the interface between the 10-Order, the revised Strategic Investment Measures and the information-reporting regime. The 10-Order remains in force until the revised version is published, but the 2026 context reinforces the policy direction and gives deal teams a stable expectation.

Three compliance screens run in parallel

A recurring theme across the 2026 documents is that easing entry does not relax screening. Inbound M&A transactions should treat three checks as parallel workstreams from the earliest structuring stage:

  1. Negative-list admission test. Confirm whether the target sector is restricted or prohibited under the current negative list, including pilot negative lists in free-trade zones. A restricted sector may still be investable through a permitted structure, but the admission position must be cleared first.
  2. Merger-control (concentration) filing. Where the transaction meets the turnover or market-share notification thresholds under the Anti-Monopoly Law, a mandatory prior filing is required; plan it as a condition to closing.
  3. Foreign-investment security review. For investments in defence-related fields or in the ten categories of important sectors where the foreign investor would obtain actual control, a security-review filing may be mandatory before implementation.

These screens interact but are distinct. The negative list governs whether the sector is open; merger control governs competitive effects; the security review governs national-security effects. Running them in parallel prevents the common failure mode of discovering a blocking issue late in diligence. The detailed security-review filing practice — including the September 2026 local service mechanisms — is addressed in our companion article on the Zhengding pilot-zone filing guide.

Practical playbook for 2026 inbound deals

1. Build the due-diligence checklist around the three screens. Map the target against the negative list, the merger-control thresholds and the security-review scope before issuing a non-binding offer; flag any sector touching the ten important-sector categories or defence-related fields for early security-review screening.

2. Plan the consideration and payment structure. Under the current 10-Order, consideration may be cash, equity or a combination, subject to the pricing basis, payment period and valuation rules. Where a cross-border share swap is contemplated, confirm whether the consideration shares are of a listed or unlisted overseas company, because the 10-Order and the revised Strategic Investment Measures treat these differently. Do not assume the relaxed rules apply until the revision is published.

3. Design the deal structure for the right regime. A controlling acquisition of an unlisted domestic target, a strategic investment in a listed company, and a concentration filing may all be triggered by one transaction; determine which regime governs each leg and sequence the approvals accordingly.

4. Manage the approval timeline explicitly. Build a timeline reflecting information reporting (ongoing), merger-control filing (where thresholds are met) and security-review filing (where in scope). Treat the security-review period as a hard freeze during which the investment may not be implemented.

5. Use the strategic-investment channel where it fits. Eligible foreign equity-investment institutions may, under the Action Plan, participate as strategic investors in non-related-industry listed-company issuances; position around the qualification and lock-up conditions as the implementing rules mature.

6. Engage local service windows early. As the Zhengding pilot zone’s September 2026 guide illustrates, local investment-service bureaus increasingly offer pre-filing coaching and preliminary review, which can shorten the path to a complete, well-formed filing.

Related reading

  • The 2026 negative list and sector-restriction map.
  • The revised Strategic Investment Measures and the CSRC refinancing rules on strategic investors.
  • Our companion article on the September 2026 foreign-investment security-review filing practice and local support mechanisms.

Sources

  • 商务部、国家发展改革委、财政部《利用外资固稳促优行动方案》(商资发〔2026〕97号):https://www.mofcom.gov.cn/zcfb/wgtzgl/art/2026/art_0cfe31a63f9c4bd3869517bc10908c10.html
  • 商务部《第26届中国国际投资贸易洽谈会将于2026年9月8日至11日举办》:https://www.mofcom.gov.cn:8443/zwjg/sqfb/oy/art/2026/art_5268bb19fa5a4ad1a07056b791afb9d7.html
  • 中国政府网《中国”十五五”规划,为世界提供新机遇》:https://www.gov.cn/yaowen/liebiao/202609/content_7081427.htm
  • 国家发展改革委:https://www.ndrc.gov.cn/
  • 商务部:https://www.mofcom.gov.cn/

中国外资并购规则:2026 年更新与对入境交易的影响

概述

2026 年,外资并购重新成为外资流入战略的关键工具。在经历以负面清单缩减、制造业准入限制全面取消为主的周期之后,政策重心正从”开放什么”转向”资本如何顺畅进入、整合与成长”。2026 年的三件进展为外国收购方提供了过去两年来最清晰的路线图:修订外资并购规则的《行动方案》具体承诺、9 月厦门投洽会上的高规格政策宣讲,以及将完善外资并购管理与拓宽外资证券市场渠道写入”十五五”规划的正式部署。

本文聚焦 2026 年 9 月的新动态与交易落地的实操步骤。我们刻意不再重复 6 月《行动方案》文本与 2006 年并购规定修订机理(相关姊妹篇已详述),并将安全审查申报细节指向另一篇专文。

2026 年 9 月的政策时刻:厦门投洽会

第 26 届中国国际投资贸易洽谈会于 2026 年 9 月 8 日至 11 日在福建厦门举行。9 月 7 日,在主体展会之前,”港通天下,链接全球”双向跨境投资交流宣介会暨出海企业高质量国际化发展对接会——投洽会”投资中国”系列专场活动之一——在厦门举办,由商务部主办,商务部投资促进事务局与厦门市商务局承办。

该场活动释放的两条信息对外资并购至关重要。其一,商务部外资司就”引进来””走出去”政策进行系统解读:在”引进来”方面,重申自 2025 年以来优化营商环境的一系列举措,包括 2026 年 6 月《行动方案》,以及升级内地与香港、澳门 CEPA、在服务业领域对港澳投资者率先开放;在”走出去”方面,指出对外投资稳步增长、内地与香港投资合作更加紧密。

其二,商务部投资促进事务局介绍了服务双向企业的路径:用好投洽会这一国家级平台,依托境外产业园等出海促进机制,并与上海虹桥国际商务区、苏州工业园区、厦门市集美区等头部集聚区共建出海服务平台,将香港的金融、法律与专业服务优势同内地的项目、园区与企业资源相连接,使更多外资借道香港进入内地、更多内地企业借助香港走向全球。

对外国收购方而言,2026 年 9 月的政策叙事是明确的双向并行:在放宽并便利入境并购的同时,通过结构化平台服务对外投资。

“十五五”规划的部署

“十五五”规划是 2026—2030 年期的首个五年规划,其中单列了吸引和利用外资的专章。在相关举措中,规划明确提出”拓展利用外资方式,完善外资并购管理,拓宽外资投资证券市场渠道”,并强调高质量实施外商投资安全审查、完善全口径外债监管体系。

这一表述将外资并购从交易层面的细分议题提升为规划级承诺,将并购管理与证券市场准入并置为统一的股权投资通道,并借由将安全审查置于同一段落,表明便利与把关同步推进。

并购现代化的《行动方案》支点

《利用外资固稳促优行动方案》(商资发〔2026〕97号)由商务部、国家发展改革委、财政部经国务院同意于 2026 年 6 月 16 日联合印发,是并购变革的操作支点。其并购相关承诺具体明确:

  • 加快修订出台关于外国投资者并购境内企业的规定,优化并购管理流程和对价支付要求;
  • 强化外资并购监管的部门协同;
  • 允许符合条件的外资股权投资机构以战略投资者身份参与非相关行业上市公司证券发行。

前两项承诺指向市场期待已久的《关于外国投资者并购境内企业的规定》(”10 号令”,2006 年)修订。核心摩擦点已广为人知:2020 年《外商投资法》施行后已不再适用的部分事前审批条款;需要在无审批网关下运行的对价与支付规则;以及 10 号令、修订后的《战略投资管理办法》与信息报告制度之间的衔接。修订版出台前 10 号令仍然有效,但 2026 年的语境强化了政策方向,为交易团队提供了可稳定预期的依据。

三重合规核查并行推进

2026 年文件反复强调的主题是:放宽准入并不放松审查。入境并购交易应从最早的结构设计阶段起,将三项核查作为并行工作流:

  1. 负面清单准入测试。 确认标的行业在现行负面清单(含自贸区试点负面清单)下属于限制还是禁止。限制类行业仍可能通过合规结构投资,但准入立场须先予厘清。
  2. 经营者集中申报。 交易达到《反垄断法》营业额或市场份额申报门槛的,须履行强制事先申报,应将其设为交割先决条件。
  3. 外商投资安全审查。 对国防领域投资,或取得十类重要领域企业实际控制权的投资,可能须在实施前强制申报。

三项核查相互关联但彼此独立:负面清单管行业是否开放,经营者集中管竞争影响,安全审查管国家安全影响。并行推进可避免尽调后期才发现阻断性问题的常见失误。安全审查申报的详细实操——包括 2026 年 9 月的地方服务机制——见本站点关于正定片区申报指引的姊妹篇。

2026 年入境交易实操手册

1. 围绕三重核查构建尽调清单。 发出无约束力要约前,将标的对照负面清单、经营者集中门槛与安全审查范围逐一映射;凡触及十类重要领域或国防相关领域的,尽早启动安全审查筛查。

2. 规划对价与支付结构。 现行 10 号令下,对价可为现金、股权或二者组合,受定价依据、支付期限与评估规则约束。若考虑跨境换股,须确认对价股份是境外上市还是非上市公司股份,因 10 号令与修订后的《战略投资管理办法》处理不同。修订版出台前,切勿假设放宽规则已适用。

3. 为适用制度设计交易结构。 一笔交易可能同时触发未上市境内标的的控股式并购、上市公司战略投资与经营者集中申报;先判定各分支由哪套制度管辖,再安排审批顺序。

4. 显式管理审批时间轴。 构建涵盖信息报告(持续)、经营者集中申报(达标时)与安全审查申报(在范围内时)的时间轴。将安全审查期间视为硬性冻结期——审查期间不得实施投资。

5. 在契合处用足战略投资通道。 依《行动方案》,符合条件的外资股权投资机构可以战略投资者身份参与非相关行业上市公司证券发行;随实施规则成熟,围绕资格与锁定期条件提前布局。

6. 尽早对接地方服务专窗。 正如正定片区 2026 年 9 月指引所示,地方投资服务部门正越来越多地提供申报前辅导与初步预审,可缩短形成完整、规范申报材料的路径。

相关阅读

  • 2026 年负面清单与分行业限制地图。
  • 修订后的《战略投资管理办法》与证监会再融资战略投资者规则。
  • 本站点关于 2026 年 9 月外商投资安全审查申报实操与地方服务机制的姊妹篇。

来源

  • 商务部、国家发展改革委、财政部《利用外资固稳促优行动方案》(商资发〔2026〕97号):https://www.mofcom.gov.cn/zcfb/wgtzgl/art/2026/art_0cfe31a63f9c4bd3869517bc10908c10.html
  • 商务部《第26届中国国际投资贸易洽谈会将于2026年9月8日至11日举办》:https://www.mofcom.gov.cn:8443/zwjg/sqfb/oy/art/2026/art_5268bb19fa5a4ad1a07056b791afb9d7.html
  • 中国政府网《中国”十五五”规划,为世界提供新机遇》:https://www.gov.cn/yaowen/liebiao/202609/content_7081427.htm
  • 国家发展改革委:https://www.ndrc.gov.cn/
  • 商务部:https://www.mofcom.gov.cn/

Mutual Recognition of Foreign Investor Credentials: The Fengtai–Qingdao Pilot and Faster Cross-City FIE Setup

  • In September 2026, the Fengtai District (Beijing) and Qingdao market-regulation authorities issued the Interim Measures on Mutual Recognition of Foreign Investors’ Eligibility Documents, effective from 9 September 2026 and valid through September 2029.
    2026 年 9 月,北京市丰台区与青岛市市场监管部门印发《开展外国投资者主体资格文件互认办法(试行)》,自 2026 年 9 月 9 日起施行,有效期至 2029 年 9 月。
  • The mechanism lets a foreign investor that has once filed and verified its eligibility documents in either Fengtai or Qingdao reuse a file-department sealed copy for a later investment in the other city, removing the need to repeat notarisation and authentication.
    该机制允许已在丰台或青岛任一地提交并核验过主体资格文件原件的外国投资者,在另一地再投资时复用登记机关档案部门加盖档案证明章的复印件,无需重复办理公证认证。
  • It covers foreign natural persons, enterprises and other organisations whose foreign-invested market entities are registered in the two localities, but excludes foreign enterprises’ resident representative offices; Hong Kong, Macao and Taiwan investors are handled by reference.
    办法覆盖在两地登记机关登记的外商投资市场主体所对应的外国自然人、企业及其他组织,不含外国企业常驻代表机构;香港、澳门、台湾地区投资者参照执行。
  • Recognition extends beyond initial incorporation to changes, deregistration, filings, equity-pledge registration and foreign-investor merger-acquisition registration that require eligibility documents.
    互认不限于设立,还适用于外商投资市场主体变更、注销登记、备案、股权出质登记以及外资并购登记中需提交主体资格文件的情形。
  • Eligibility requires the original to be within its validity period, or — where no period is specified — the notarised and authenticated document to be within one year; the investor must confirm the copied information matches its current status.
    适用前提是原件在有效期内,或无明确有效期时公证认证文件在 1 年以内;投资者须确认复印件所记载信息与其当前情况一致。
  • Handling is online via Beijing’s enterprise e-window platform, with a statutory time limit of six working days and a committed time limit of zero working days; the consultation line is 010-63397070.
    办理通过北京市企业服务 e 窗通平台网上进行,法定办结时限 6 个工作日、承诺办结时限 0 个工作日;咨询电话 010-63397070。
  • The pilot builds on Fengtai’s 2025 mutual-recognition with Hangzhou and Foshan — which cut processing from about 15 days to as fast as one day — and extends the foreign-investment commercial-service network to cover the Beijing-Tianjin-Hebei core, the Yangtze River Delta, the Pearl River Delta and the Jiaodong coast.
    该试点建立在丰台 2025 年与杭州、佛山三地互认的基础之上——企业办事周期由约 15 天压缩至最快 1 天——并将外资商事服务协作网络拓展至覆盖京津冀核心、长三角、珠三角与胶东沿海。

Mutual Recognition of Foreign Investor Credentials: The Fengtai–Qingdao Pilot and Faster Cross-City FIE Setup | 外国投资者主体资格文件跨区域互认:丰台—青岛”一次核验、两地通用”机制

Overview

Cross-city investment by a foreign investor in China has long carried a hidden cost: every time the investor sets up or changes a foreign-invested enterprise (FIE) in a new city, it must re-submit its eligibility documents — the notarised and authenticated proof of legal status — often repeating notarisation, authentication and cross-border mailing. In September 2026, the Fengtai District Administration for Market Regulation (Beijing) and the Qingdao Administration for Market Regulation jointly issued the Interim Measures on Mutual Recognition of Documents Evidencing the Legal Status of Foreign Investors (Trial), creating a “verify once, use in both places” channel between the two cities. The Measures took effect on 9 September 2026 and are valid through September 2029.

The instrument is narrow but high-leverage: it does not change what an eligibility document must contain, nor exempt an investor from notarisation and authentication the first time around. It removes the repetition — the second-city filing relies on a sealed copy from the first city’s archive plus a mutual-recognition form, turning a weeks-long document cycle into a same-day internal step for a multi-city China footprint.

Who is covered

The Measures apply to foreign-invested market entities registered with the market-entity registration authorities in Fengtai District (Beijing) and in Qingdao. “Foreign investor” means a foreign natural person, enterprise or other organisation. Two boundaries matter.

  • Excluded. Foreign enterprises’ resident representative offices are not covered.
  • By reference. Investors from the Hong Kong Special Administrative Region, the Macao Special Administrative Region and the Taiwan Region are handled in accordance with the Measures.

The underlying logic is reciprocity within the two-city network: an investor that has cleared the document hurdle in one city should not clear it again in the other, provided the file is still good.

When recognition applies

Article 5 sets the trigger. Where a foreign investor has already established a foreign-invested market entity with either the Fengtai or the Qingdao registration authority and has submitted the original notarised and authenticated eligibility documents, and those documents remain within their validity period — or, where no validity period is specified, the notarised and authenticated documents were issued within one year — the investor may, when investing in the other locality, submit a photocopy of those documents bearing the archival seal of the registration authority where the existing entity was established, together with a completed Application for Mutual Recognition of Documents Evidencing the Legal Status of Foreign (Regional) Investors.

Two subtleties are worth noting. First, if the original eligibility document itself restricts its first use to a specific area, both localities recognise that restriction in the mutual-recognition step. Second, under Article 6 the investor submitting the photocopy must confirm that the information recorded on it is consistent with its current circumstances and is true and accurate — recognition does not waive the duty to keep the investor’s particulars current.

Article 7 widens the scope beyond incorporation. The Measures also apply where a foreign investor must submit eligibility documents in connection with the change of registration, cancellation of registration, filing, registration of equity pledge, or registration of foreign-investor merger and acquisition of a foreign-invested market entity. In practice, that means a recognised copy can serve a change, a deregistration, a filing, an equity-pledge registration or an inbound M&A filing in the partner city.

What counts as an eligibility document

  • For a foreign investor, the eligibility document is the proof of legal status notarised by the competent authority of the investor’s home country and authenticated by the Chinese embassy or consulate there; or notarised by a third country’s embassy or consulate in that country (with diplomatic ties to China) and authenticated by the Chinese embassy or consulate in that third country.
  • Where the investor’s home country is a party to the Convention Abolishing the Requirement of Legalisation for Foreign Public Documents, the eligibility document is the home-country notarial certificate together with the apostille issued by the competent authority thereof.
  • For Hong Kong, Macao and Taiwan investors, the eligibility document is the notarial document issued by the relevant notarial authority of the region under the applicable special provisions or arrangements.

The Measures also track the State Administration for Market Regulation’s submission requirements: where those requirements change, the latest requirements prevail. This keeps the recognised document in step with any future national rule change.

Channel and timeline

Applications are handled online through Beijing’s enterprise e-window platform (the municipal one-stop enterprise service portal). The statutory time limit for completion is six working days; the committed time limit is zero working days. The consultation telephone is 010-63397070.

Institutional background

The Fengtai–Qingdao pilot is the latest expansion of a deliberate network. In 2025, Fengtai reached mutual-recognition arrangements with Hangzhou and Foshan — a three-city “verify once, use in three places” channel linking the Beijing-Tianjin-Hebei core, the Yangtze River Delta and the Pearl River Delta — which compressed the enterprise handling cycle from about 15 days to as fast as one day. In 2026, Fengtai extended the partner circle to Qingdao, an important foreign-investment cluster on the Jiaodong coast, leveraging the Beijing–Shanghai high-speed-rail corridor. The result is a foreign-investment commercial-service network spanning the Beijing-Tianjin-Hebei core, the Yangtze River Delta, the Pearl River Delta and the Jiaodong coast, with unified standards for accepting registration materials across administrative boundaries.

The legal basis is the Foreign Investment Law and its implementing regulations, together with Beijing’s market-regulation measures to promote high-quality development of market entities. The direction is clear: more cities, more standardised mutual acceptance, and a progressively lighter document burden for cross-city foreign investment.

Practical self-check for foreign investors

For a foreign group planning or running a multi-city China presence, the following points determine whether the mutual-recognition route applies.

  1. First-city footing. Have you already incorporated or registered a foreign-invested market entity in Fengtai or Qingdao, with the original notarised and authenticated eligibility documents on file? Without that first footprint, recognition cannot start.
  2. Validity clock. Is the original still within its stated validity period, or — if none is stated — was the notarisation and authentication issued within the last year? If the clock has run out, a fresh document is needed first.
  3. Information consistency. Does the copied file still reflect the investor’s current particulars — name, structure, authorised signatories? If the investor has since restructured, the copy may need updating before it can serve.
  4. Scope of use. Recognition covers not only a new incorporation but also changes, deregistration, filings, equity pledges and inbound M&A filings in the partner city.
  5. When re-notarisation is still required. If the original has expired or fallen outside the one-year window, or the investor’s legal status has materially changed, a fresh notarised and authenticated document (or apostille, for Convention parties) is required rather than a sealed copy.

Working with the Apostille route

The mutual-recognition mechanism and the Hague Apostille route are complementary, not substitutes. For investors from countries party to the Convention Abolishing the Requirement of Legalisation for Foreign Public Documents, the first-time document is already lighter — a notarial certificate plus an apostille, instead of consular legalisation. Mutual recognition then removes the need to produce even that lighter package a second time within the two-city network. For investors from non-Convention countries, the consular-authentication route still applies for the first filing; mutual recognition then spares the repeat of that route in the partner city.

Sources

  • 北京市丰台区人民政府(办法通知原文):《关于印发开展外国投资者主体资格文件互认办法(试行)的通知》:https://www.bjft.gov.cn/xxfb/ftzcwj/ftbmwj/202609/t20260907_224263.shtml
  • 北京市丰台区人民政府(文字解读):《开展外国投资者主体资格文件互认办法(试行)》文字解读:https://www.bjft.gov.cn/xxfb/ftzcjd/202609/t20260907_224264.shtml
  • 北京市人民政府(起草说明):《开展外国投资者主体资格文件互认办法(试行)(征求意见稿)》起草说明:https://www.beijing.gov.cn/hudong/gfxwjzj/qjzjxx/202607/P020260720593097897412.docx
  • 北京市企业服务 e 窗通平台(网上办理入口):https://ect.scjgj.beijing.gov.cn
  • 国家市场监督管理总局(提交材料规范依据):https://www.samr.gov.cn/
  • 北京市丰台区人民政府(动态新闻:一次核验,两地通用!丰台新政上线):https://www.bjft.gov.cn/xwdt/jcdt/bmdt/202609/t20260911_224628.shtml
  • 北京市丰台区人民政府(英文版通知):https://www.bjft.gov.cn/c100291/c100292/202609/t20260909_224506.shtml

外国投资者主体资格文件跨区域互认:丰台—青岛”一次核验、两地通用”机制

概述

外国投资者在中国跨城市投资,长期隐含一项成本:每次在新城市设立或变更外商投资企业,都须重新提交主体资格文件——经公证认证的主体资格证明——往往要重复办理公证、认证与跨境邮寄。2026 年 9 月,北京市丰台区市场监督管理局与青岛市市场监督管理局联合印发《开展外国投资者主体资格文件互认办法(试行)》,在两地之间开通”一次核验、两地通用”通道。办法自 2026 年 9 月 9 日起施行,有效期至 2029 年 9 月。

该工具范围窄但杠杆高:它不改变主体资格文件的内容要求,也不豁免投资者首次的公证认证义务,它消除的是”重复”——第二地的登记可凭第一地登记档案中加盖档案证明章的复印件、加一份互认申请书办理。对在中国多城市布局的外国投资集团而言,这把原本数周的文件周期压缩为当日即可完成的内部分步。

适用对象

办法适用于在北京市丰台区、青岛市市场主体登记机关登记的外商投资市场主体。所称”外国投资者”,指外国的自然人、企业或者其他组织。两条边界需注意。

  • 排除项。 外国企业常驻代表机构不在覆盖范围内。
  • 参照执行。 香港特别行政区、澳门特别行政区、台湾地区的投资者参照本办法执行。

其底层逻辑是两地网络内的对等:投资者在一地跨过文件门槛后,只要文件仍有效,不应在另一地再次跨过。

互认的适用情形

第五条设定触发条件。外国投资者已在丰台区或青岛市任一登记机关设立外商投资市场主体,并提交过经公证认证的主体资格文件原件,且文件在有效期内——或无明确有效期、公证认证文件在 1 年以内的——该外国投资者再向其他一地投资的,可提供由已设外商投资市场主体登记机关档案部门出具的、加盖档案证明章的主体资格文件复印件,并填写《外国(地区)投资者主体资格文件互认申请书》。

两点细节值得注意。其一,若主体资格文件原件首次限定了适用区域,两地在互认中均认可该限定。其二,依第六条,提交复印件的外国投资者应确认复印件所记载信息与其当前情况一致、真实准确——互认不免除投资者保持自身信息最新的义务。

第七条将范围由设立拓宽。外商投资市场主体变更、注销登记、备案、股权出质登记以及外资并购登记中需要外国投资者提交主体资格文件的,同样适用本办法。实践中这意味着,一份获认可的复印件可服务于合作城市的变更登记、注销登记、备案、股权出质登记或入境并购登记。

何为合格的主体资格文件

  • 对外国投资者,主体资格文件指经其本国主管机关公证、并送中国驻该国使(领)馆认证的文件;或送与中国有外交关系的第三国驻该国使(领)馆认证、再送我国驻该第三国使(领)馆认证的文件。
  • 投资者所属国为《取消外国公文书认证要求的公约》缔约国的,主体资格文件指其本国主管机关出具的公证文书,连同当地有权机关签发的附加证明书(Apostille)。
  • 香港、澳门、台湾地区投资者,按专项规定或协议依法提供当地公证机构出具的公证文件。

办法同时对接国家市场监督管理总局的提交材料规范:规范发生变化的,以最新要求为准。这使获认可的文件始终与可能的全国性规则变动保持一致。

办理渠道与时限

申请通过北京市企业服务 e 窗通平台网上办理(市级一站式企业服务平台)。法定办结时限 6 个工作日,承诺办结时限 0 个工作日。咨询电话 010-63397070。

制度背景

丰台—青岛试点是一张有意拓展的网络的最新一环。2025 年,丰台已与杭州、佛山达成三地互认,以”一次核验、三地通用”通道连通京津冀核心、长三角与珠三角,将企业办事周期由约 15 天压缩至最快 1 天。2026 年,丰台将伙伴圈拓展至胶东沿海重要外资集聚城市青岛,依托京沪高铁经济走廊形成高效通达的产业联动,由此形成覆盖京津冀核心、长三角、珠三角、胶东沿海的外资商事服务协作网络,打破行政区划壁垒、统一商事登记材料采信标准。

制定依据为《中华人民共和国外商投资法》及其实施条例,以及北京市自身促进市场主体高质量发展的登记工作措施。方向清晰:更多城市、更标准化的互认采信、对外资跨城投资逐步减轻的文件负担。

外国投资者适用条件自查清单

对计划或正在中国多城市布局的外国投资集团,以下要点可判断互认路径是否适用。

  1. 第一地基础。 是否已在丰台或青岛设立或登记过外商投资市场主体,并将经公证认证的主体资格文件原件归档?无此第一处落脚点,互认无从启动。
  2. 有效期时钟。 原件是否仍在载明有效期内;或虽无明确有效期,公证认证是否发生在最近一年内?时钟走完,须先换新文件再谈互认。
  3. 信息一致性。 复印件是否仍反映投资者当前情况——名称、架构、授权签字人?若投资者此后重组,复印件可能需更新方可使用。
  4. 使用范围。 互认不仅适用于新设,也适用于合作城市的变更登记、注销登记、备案、股权出质登记与入境并购登记。
  5. 仍须重新公证认证的情形。 若原件已过期或超出一年窗口,或投资者法律地位发生重大变化,须重新提交经公证认证的文件(缔约国则为附加证明书),而非档案复印件。

与海牙附加证明书路径的配合

互认机制与海牙附加证明书(Apostille)路径是互补而非替代。对来自《取消外国公文书认证要求的公约》缔约国的投资者,首次文件已较轻——公证文书加附加证明书,而非领事认证。互认机制进而免去在两地网络内第二次出具该较轻套装。对非缔约国投资者,首次仍走领事认证路径;互认机制则免去在合作城市的重复出具。

来源

  • 北京市丰台区人民政府(办法通知原文):《关于印发开展外国投资者主体资格文件互认办法(试行)的通知》:https://www.bjft.gov.cn/xxfb/ftzcwj/ftbmwj/202609/t20260907_224263.shtml
  • 北京市丰台区人民政府(文字解读):《开展外国投资者主体资格文件互认办法(试行)》文字解读:https://www.bjft.gov.cn/xxfb/ftzcjd/202609/t20260907_224264.shtml
  • 北京市人民政府(起草说明):《开展外国投资者主体资格文件互认办法(试行)(征求意见稿)》起草说明:https://www.beijing.gov.cn/hudong/gfxwjzj/qjzjxx/202607/P020260720593097897412.docx
  • 北京市企业服务 e 窗通平台(网上办理入口):https://ect.scjgj.beijing.gov.cn
  • 国家市场监督管理总局(提交材料规范依据):https://www.samr.gov.cn/
  • 北京市丰台区人民政府(动态新闻:一次核验,两地通用!丰台新政上线):https://www.bjft.gov.cn/xwdt/jcdt/bmdt/202609/t20260911_224628.shtml
  • 北京市丰台区人民政府(英文版通知):https://www.bjft.gov.cn/c100291/c100292/202609/t20260909_224506.shtml

Red-Chip and VIE Structures in China: Substance-Over-Form Scrutiny and the 2026 Offshore Listing Filing Path

  • China applies a substance-over-form principle to red-chip and VIE structures: the architecture cannot be used to circumvent foreign-investment admission, technology-export control, data-export and outbound-investment requirements.
    中国对红筹与 VIE 架构适用实质重于形式的穿透原则:架构设计不得用于规避外商投资准入、技术出口管制、数据出境与对外投资管理的要求。
  • The Ministry of Commerce has publicly stated that enterprises engaged in outbound investment, technology export, data export and cross-border M&A must comply with Chinese laws and fulfil statutory procedures.
    商务部已公开表态,企业从事对外投资、技术出口、数据出境、跨境并购等活动,须符合中国法律法规并履行法定程序。
  • The CSRC offshore-listing filing regime covers both direct (H-share) and indirect (red-chip/VIE) issuers; the channel remains open in 2026.
    证监会境外上市备案制覆盖直接(H 股)与间接(红筹/VIE)发行人;2026 年通道保持开放。
  • On 4 September 2026 the CSRC published its filing-status table; on 18 September 2026 it issued the filing notice for Jiangsu Xinde Semiconductor’s Hong Kong IPO and full-circulation conversion.
    2026 年 9 月 4 日,证监会发布备案情况表;9 月 18 日发布江苏芯德半导体香港 IPO 及”全流通”备案通知书。
  • A filing notice confirms only the filing information, not the investment value or the truthfulness of the materials — a procedural acknowledgement, not a substantive endorsement.
    备案通知书仅确认备案信息,不代表对投资价值或备案材料真实性、准确性、完整性作出判断或保证,属于程序性确认而非实质性背书。
  • Architecture choice turns on red-chip (Cayman + Hong Kong + WFOE) versus H-share direct listing, the 37-Article SAFE registration path, the compliant boundary of VIE in restricted sectors, and the tax and FX effects of building or dismantling a structure.
    架构选择取决于红筹(开曼+香港+WFOE)与 H 股直接上市的比较、37 号文登记路径、VIE 在受限行业的合规边界,以及搭建或拆除架构的税务与外汇影响。
  • Practical readiness means a clean filing timeline, complete materials, ongoing major-event and post-listing reporting, and anticipation of look-through, data/algorithm and industry-admission inquiries.
    实操要点是清晰的备案时间轴、完整材料、持续的重大事项与上市后报告义务,并预判股权穿透、数据与算法合规、行业准入资质三类问询。

Red-Chip and VIE Structures in China: Substance-Over-Form Scrutiny and the 2026 Offshore Listing Filing Path | 红筹与 VIE 架构在中国:实质重于形式的穿透式监管与 2026 年境外上市备案路径

Overview

For two decades, red-chip and Variable Interest Entity (VIE) structures have been the main vehicles for China-based businesses to raise capital offshore while operating in foreign-investment-restricted sectors at home. The 2026 environment is neither a ban nor a free pass; it is a filing-based regime built on one idea: substance over form. A structure’s legal label does not alone determine how the business is treated for admission, export-control, data and outbound-investment purposes — what matters is where the assets, control, revenue and compliance obligations actually sit.

This article sets out the penetration principle across the four regulatory gates most relevant to red-chip and VIE planning — admission, technology export, data export and outbound investment — then walks through the CSRC filing path as it stands in September 2026, including the latest public filing instances and the methodology for choosing a compliant structure.

The substance-over-form penetration principle

The clearest official articulation came from the Ministry of Commerce. Its spokesperson stated that the Chinese government consistently supports enterprises in conducting mutually beneficial cross-border operations and international technology cooperation in accordance with law, and that enterprises engaged in outbound investment, technology export, data export and cross-border M&A must comply with Chinese laws and fulfil statutory procedures. The ministry added that it would, with relevant departments, assess a transaction’s consistency with export-control, technology import/export and outbound-investment rules.

That is a statement of method, not a single deal. For a red-chip or VIE group, the offshore layer is transparent to the four gates:

  • Foreign-investment admission. The negative list and its application guidance look through to the ultimate controller; a VIE does not convert a prohibited activity into a permitted one.
  • Technology export. Where the underlying assets or know-how are subject to technology-import/export administration, the offshore restructuring and any transfer of control must clear the applicable export-control and technology-transfer procedures.
  • Data export. Data-export security assessment, standard contracts and certification apply to the domestic operating entity regardless of how the group is held offshore; cybersecurity-review obligations for large user bases travel with the data.
  • Outbound investment. Corporate and individual outbound investments are administered under the State Council’s unified rules; the ODI filings and approvals sit underneath any offshore listing and cannot be designed around.

The CSRC offshore-listing filing regime

Since 31 March 2023, the CSRC has administered offshore securities offerings and listings by domestic enterprises through a unified filing system under the *Trial Measures for the Administration of Overseas Securities Offering and Listing by Domestic Companies*. It covers both direct listings (H-shares) and indirect listings (red-chip/VIE structures, where an offshore entity lists based on the assets, revenue or earnings of a domestic operating entity).

The indirect-listing test is itself substance-over-form: a domestic entity is deemed the issuer where, in the latest year, any of revenue, profit, total assets or net assets exceeds 50% of the consolidated figure and the main business is conducted in China. A domestic responsible person must be designated to file with the CSRC. For H-share issuers converting domestic unlisted shares into overseas-listed shares, the *Business Guideline for the “Full Circulation” of Unlisted Domestic Shares of H-share Companies* provides the framework. VIE is not prohibited; the CSRC grants filing where compliance is satisfied, and the channel has remained operational through 2026.

September 2026 filing snapshots

On 4 September 2026 the CSRC released its rolling IPO and full-circulation filing-status table as of that date; in it, the Hong Kong IPO filings of enterprises spanning cross-border logistics, new energy, high-end manufacturing, biomedicine and cultural-tourism consumption appeared in “received” (已接收) status, while one A-share company’s Hong Kong IPO filing appeared in “seeking comments” (征求意见) status.

On 18 September 2026 the CSRC’s International Department issued the filing notice for Jiangsu Xinde Semiconductor Technology Co., Ltd. concerning its overseas offering, listing and full-circulation of domestic unlisted shares (document reference 国合函〔2026〕2003号; dated 20 August 2026, published 18 September 2026):

  • No more than 367,640,500 overseas-listed ordinary shares to list on The Stock Exchange of Hong Kong.
  • 51 shareholders to convert an aggregate of 693,909,187 domestic unlisted shares into overseas-listed shares for trading on the Hong Kong exchange; names and quantities are attached.
  • Report material events through the CSRC filing management information system from the notice date until the offering concludes.
  • Report the listing particulars within 15 working days of completion, complying with both jurisdictions’ laws throughout.
  • If not completed within 12 months of the notice and intended to continue, update the filing materials.

The legal nature of the filing notice

A frequently misunderstood point is what the filing notice does and does not do. The CSRC’s notices state expressly that the notice only confirms the filing information. It does not indicate a substantive judgment or guarantee as to the investment value or investors’ returns, nor that the CSRC guarantees or recognises the truthfulness, accuracy or completeness of the enterprise’s filing materials.

In other words, the notice is a procedural acknowledgement, not a merit review and not a clean bill of health on the underlying business.

Architecture-choice methodology

Choosing between a red-chip structure and an H-share direct listing is a commercial and regulatory decision:

  • Red-chip (Cayman holding + Hong Kong intermediate + WFOE). The three-tier offshore structure raises capital offshore while the WFOE holds lawfully ownable licences and wraps the domestic operating entity in contractual control; its cost is the full evidence chain (37-Article SAFE, ODI and FDI foreign-exchange registration, and clean documentation for every capital reduction, buyback and transfer).
  • H-share direct listing. The domestic company lists directly overseas with its domestic shares converted where applicable under the full-circulation framework, avoiding the offshore holding layer and the associated ODI and 37-Article steps, but tying the listed vehicle to the domestic legal person.
  • The 37-Article registration path. Founders and employees holding offshore equity through special-purpose vehicles register with SAFE under the rules on foreign-exchange administration for overseas investment and financing by domestic residents; this is a recurring focus of pre-filing review.
  • The compliant boundary of VIE. In restricted (non-prohibited) sectors, a VIE may be acceptable where the structure and foreign-investment compliance are fully disclosed and approvals obtained; in prohibited sectors, a VIE cannot rescue the business. The negative-list status of the operating activity is therefore the first question.
  • Tax and FX effects of building or dismantling. Establishing or unwinding a structure can trigger valuation, pricing and tax consequences at the WFOE-OPCO interface and on cross-border payments; exchange-control documentation must be maintained and modelled before filing.

Practical steps for filers

  1. Map the negative-list and gate exposure first. Confirm whether the activity is prohibited, restricted or open, and which of the four gates apply.
  2. Choose the structure on the evidence chain. If red-chip, build the 37-Article, ODI and FDI registration trail before filing; if H-share, prepare the full-circulation conversion schedule.
  3. Prepare the filing materials. Disclose the control arrangement fully, designate a domestic responsible person, and align the materials with the substance-over-form test.
  4. Run the look-through before it is asked. Identify every 5%-plus shareholder, aggregate connected holdings, surface Chinese-natural-person investors behind offshore funds, and resolve nominee arrangements.
  5. Anticipate the three recurring inquiry themes: filers are routinely examined on equity-structure look-through, data and algorithm compliance, and industry-admission qualifications.
  6. Honour the ongoing obligations. Report material events during the pre-listing window, report the listing within 15 working days of completion, and update the filing if the 12-month validity lapses without completion.

Sources


红筹与 VIE 架构在中国:实质重于形式的穿透式监管与 2026 年境外上市备案路径

概述

二十年来,红筹架构与协议控制(VIE)架构一直是中国境内企业赴境外融资、同时运营受外资限制行业的主要载体。2026 年的监管环境既不禁止、也非放任,而是一套以”实质重于形式”为内核的备案制框架:结构的法律标签本身并不单独决定业务在准入、出口管制、数据出境与对外投资等维度上如何被对待,真正决定待遇的是资产、控制、收入与合规义务的实际所在。

本文先阐明与红筹和 VIE 规划最密切的四道监管闸门所共同遵循的穿透原则——外商投资准入、技术出口、数据出境与对外投资,再梳理截至 2026 年 9 月的证监会境外上市备案路径,包括最新公开的备案实例与选择合规架构的方法论。

实质重于形式的穿透原则

对跨境架构穿透原则最明确的官方表述来自商务部。商务部新闻发言人表示,中国政府一贯支持企业依法依规开展互利共赢的跨国经营与国际技术合作,并说明企业从事对外投资、技术出口、数据出境、跨境并购等活动,须符合中国法律法规,履行法定程序;商务部将会同相关部门对交易与出口管制、技术进出口、对外投资等相关法律法规的一致性开展评估调查。

这一表态针对的是方法,而非单一交易。对红筹或 VIE 集团而言,其含义是离岸层级在四道闸门的监管者面前是透明的:

  • 外商投资准入。 负面清单及其适用指引穿透至最终实际控制人;VIE 无法把禁止类业务变成允许类。
  • 技术出口。 当底层资产或技术受技术进出口管理时,离岸重组及任何控制权转移都须完成相应的出口管制与技术进出口程序。
  • 数据出境。 数据出境安全评估、标准合同与认证适用于境内运营实体,与集团在离岸如何持股无关;对大规模用户群体的网络安全审查义务随数据走。
  • 对外投资。 企业与个人的对外投资依国务院统一规则管理;ODI 备案与核准位于任何境外上市之下,不得以架构设计绕开。

证监会境外上市备案制度

自 2023 年 3 月 31 日起,中国证监会对境内企业境外发行证券和上市统一实行备案制,依据《境内企业境外发行证券和上市管理试行办法》。该制度覆盖直接上市(H 股)与间接上市(红筹/VIE 架构,由境外主体基于境内运营实体的资产、收入或收益上市)。

间接上市测试本身就是实质重于形式的测试:境内实体若最近一会计年度营业收入、利润总额、总资产或净资产任一指标超过合并报表相应数据的 50%,且主要业务在境内开展,则认定为发行人;并须指定境内责任人向证监会备案。对拟将境内未上市股份转为境外上市股份的 H 股发行人,《H 股公司境内未上市股份申请”全流通”业务指引》提供了框架。VIE 未被禁止;证监会在满足合规要求时予以备案,2026 年通道保持运转。

2026 年 9 月备案实例

证监会 2026 年 9 月 4 日发布的截至当日首次公开发行及全流通备案情况表中,覆盖跨境物流、新能源、高端制造、生物医药、文旅消费等赛道的众多企业香港 IPO 备案状态为”已接收”,一家 A 股上市公司的香港 IPO 备案状态为”征求意见”。

2026 年 9 月 18 日,证监会国际合作司发布关于江苏芯德半导体科技股份有限公司境外发行上市及境内未上市股份”全流通”的备案通知书(国合函〔2026〕2003 号;落款 2026 年 8 月 20 日,2026 年 9 月 18 日公示):

  • 拟发行不超过 367,640,500 股境外上市普通股,并在香港联合交易所上市。
  • 51 名股东拟将所持合计 693,909,187 股境内未上市股份转为境外上市股份,在香港联合交易所上市流通;股东名称及转换数量附后。
  • 自本备案通知书出具之日起至本次境外发行上市结束前,如发生重大事项,应通过中国证监会备案管理信息系统报告。
  • 完成境外发行上市后 15 个工作日内,应通过该备案管理信息系统报告发行上市情况,并在过程中严格遵守境内外有关法律、法规和规则。
  • 自备案通知书出具之日起 12 个月内未完成境外发行上市及股份转换、拟继续推进的,应当更新备案材料。

备案通知书的法律性质

首次申报者常误解备案通知书的作用范围。证监会通知书明确声明,仅对企业境外发行上市及”全流通”备案信息予以确认,不表明证监会对该企业证券的投资价值或者投资者的收益作出实质性判断或者保证,也不表明对备案材料的真实性、准确性、完整性作出保证或者认定。

换言之,通知书是对备案的程序性确认,而非价值判断,也不构成对底层业务的合规背书。

架构选择方法论

在红筹架构与 H 股直接上市之间取舍,是商业与监管并重的决策:

  • 红筹架构(开曼控股+香港中间公司+WFOE)。 三层离岸架构在境外募资,WFOE 持有外资可合法拥有的牌照,并以合同控制包裹境内运营实体。其代价是完整的证据链:创始人的离岸特殊目的公司须办理 37 号文外汇登记,企业投资者须办理 ODI 备案,返程 WFOE 须办理 FDI 外汇登记,且历次减资、回购与转让均须文件清晰。
  • H 股直接上市。 境内企业直接在境外交易所上市,并在全流通框架下视情况转换境内股份,免去了离岸控股层及相应的 ODI 与 37 号文步骤,但将上市主体绑定于境内法人。
  • 37 号文登记路径。 通过特殊目的公司持有离岸权益的创始人与员工,依境内居民境外投融资外汇管理规定在外汇局办理登记;该登记是备案前审查的反复重点。
  • VIE 的合规边界。 在限制类(非禁止类)行业,在架构与外资合规充分披露并取得相应审批后,VIE 或可被接受;在禁止类行业,VIE 无法拯救业务。因此运营活动的负面清单属性是首要问题。
  • 搭建或拆除的税务与外汇影响。 设立或拆解架构可能在 WFOE 与运营实体的接口及跨境支付环节触发估值、定价与税务后果;须持续维护外汇监管文件,并在申报前建模测算。

申报企业实操步骤

  1. 先梳理负面清单与闸门暴露面。 确认运营活动属禁止、限制还是开放,并识别四道闸门中哪些适用。
  2. 按证据链选择架构。 若选红筹路径,在申报前备齐 37 号文、ODI 与 FDI 登记轨迹;若选 H 股路径,备好全流通转换时间表。
  3. 准备备案材料。 完整披露控制安排,指定境内责任人,并使材料契合实质重于形式测试。
  4. 主动做穿透自查。 摸清每个 5% 以上股东,合并计算关联持股,识别境外基金背后的中国籍自然人,清理代持安排。
  5. 预判三类反复出现的问询主题: 申报企业通常被审查股权结构穿透、数据与算法合规、行业准入资质。
  6. 履行持续义务。 在上市前窗口内报告重大事项,于完成后 15 个工作日内报告上市情况,若 12 个月有效期届满仍未完成则更新备案材料。

来源

Registered Capital for Foreign-Invested Enterprises in China: Contribution Deadlines and 2026 Filing Rules

  • Under the Company Law effective 1 July 2024, limited-liability shareholders must pay up subscribed capital within five years of incorporation, and pre-2024 companies whose remaining subscription term exceeds five years from 1 July 2027 must compress it to within five years by 30 June 2027 — the single most urgent compliance deadline for foreign-invested enterprises today.
    2024 年 7 月 1 日施行的《公司法》要求有限责任公司股东自成立之日起五年内缴足认缴出资;2024 年 6 月 30 日前设立、剩余认缴期限自 2027 年 7 月 1 日起超过五年的存量公司,须在 2027 年 6 月 30 日前压缩至五年以内——这是当前外资企业最紧迫的合规截止日。
  • The 2026 versions of SAMR’s registration document and submission-material standards (effective 1 May 2026) add the capture of shareholders’ contribution-term information and new filing materials for capital changes caused by shareholder forfeiture and loss-offsetting capital reduction, giving the new Company Law effect at the registry level.
    市场监管总局 2026 年版登记文书规范与提交材料规范(2026 年 5 月 1 日施行)新增股东出资期限信息采项,并补充股东失权、弥补亏损减资的资本变更登记材料,在登记机关层面落实新《公司法》。
  • For foreign-invested enterprises, capital must be remitted by the overseas shareholder in foreign exchange or cross-border RMB into a capital account; domestic funds may not be used to advance or substitute registered capital, and the contribution method must align with SAFE registration and a verifiable valuation and audit trail.
    外资企业的资本金须由境外股东以现汇或跨境人民币汇入资本金账户,不得以境内资金垫资或充抵注册资本,出资方式须与外汇登记衔接,并留存可核查的评估与审计凭证。
  • Under Enterprise Bankruptcy Law Article 35, once a court accepts a bankruptcy petition, the administrator may demand that shareholders pay subscribed capital in full regardless of the original subscription term, and public recovery notices posted on the national bankruptcy restructuring information platform illustrate this in practice.
    依据《企业破产法》第三十五条,人民法院受理破产申请后,管理人可要求股东不受原认缴期限限制缴纳所认缴出资,全国企业破产重整案件信息网公开的管理人追缴出资公告即为实务例证。
  • Capital reduction for an FIE follows the ordinary route of creditor notice and public announcement plus change registration, while loss-offsetting reductions and forfeiture-driven reductions follow the special materials set out in the 2026 standards.
    外资企业减资按普通路径履行债权人通知与公告并办理变更登记;弥补亏损减资与失权减资则适用 2026 版规范设定的专门材料。
  • Practical agenda: model each entity’s five-year schedule, decide the transition path before mid-2027, align the capital-remittance route and timing with SAFE steps, and avoid the common pitfalls of assuming legacy long terms survive and forgetting the 20-working-day publicity.
    实操议程:逐实体测算五年出资排期,于 2027 年年中前确定过渡路径,将出资汇入路径与时间安排与外汇步骤对齐,并规避”旧长周期仍有效””漏掉 20 个工作日公示”等常见误区。

Registered Capital for Foreign-Invested Enterprises in China: Contribution Deadlines and 2026 Filing Rules | 外商投资企业的注册资本认缴与出资期限管理(2026 年口径)

Overview

The registered-capital regime is the first capital decision a foreign investor makes when incorporating in China. In 2026 it sits at the intersection of three binding instruments: the revised Company Law (effective 1 July 2024), the State Council’s registered-capital regulation, and the market-registry filing standards. The defining feature is the five-year paid-in deadline replacing open-ended subscription; its flashpoint is 30 June 2027, by which pre-July-2024 companies with long residual terms must compress those terms to within five years and record the change. This article explains the deadline, the 2026 filing changes, the foreign-exchange dimension, bankruptcy acceleration and the capital-reduction procedure, then gives a practical checklist.

The five-year rule and the 2027 transition deadline

Under the revised Company Law, a limited-liability company’s registered capital is the total subscribed by all shareholders, and all shareholders must pay their subscribed capital in full within five years from incorporation; a joint-stock company’s promoters must pay the full amount before incorporation.

For companies established before 1 July 2024 — the category that includes most existing foreign-invested enterprises — the State Council regulation gives a transition rule. Where the remaining subscription term exceeds five years from 1 July 2027, the company must adjust the remaining term to within five years and record the change in its articles by 30 June 2027, and shareholders must pay within the adjusted term. Narrow exceptions exist for companies involving national interest or major public interest, and abnormally long or large terms may be required to be adjusted after assessment.

The compliance calendar matters more than the principle. A WFOE incorporated in 2019 with a 30-year schedule under its old articles — routine before 2024 — now faces a forcing function. The calculation is mechanical: if the span from 1 July 2027 to the old maturity exceeds five years, the residual term must be compressed so payment falls due no later than 30 June 2032, and the amended term recorded by 30 June 2027.

Contribution methods and the foreign-invested specifics

The contribution menu is broad — cash, in-kind assets, intellectual property, land-use rights, equity, claims, and, where permitted, data and network virtual-property rights — all subject to valuation. For foreign-invested enterprises three points stand out. Capital must settle into a SAFE capital account via foreign exchange or cross-border RMB; domestic funds may not advance or substitute it, and treating intra-group renminbi as paid-in is the most common error. The subscribed and paid-in figures in the SAMR filing, the credit-information system and the SAFE registration must match — for currency, the bank records the monetary contribution on receipt before the funds become usable; for non-currency, a valuation report and title transfer are needed. The company must keep valuation reports, contribution records and verification or audit evidence; the 2026 standards reinforce this with per-shareholder contribution-term capture and real-name forms.

The 2026 registration document and material standards

The 2026 versions of the registration document and submission-material standards (SAMR document No. 5 of 2026, effective 1 May 2026) translate the new Company Law into registry-level paperwork.

The standards change the incorporation form’s “contribution date” field to “contribution term”, requiring each subscription to state its amount, method and payment-window dates — building the data basis for the demand and forfeiture procedures. They add a shareholder register as a filing material for capital and shareholder changes and contribution-information filings, giving effect to the new Company Law’s recognition of the register as the basis for shareholder rights.

Two new scenarios gain specific materials. For shareholder forfeiture after a written demand and grace period, the company may forfeit the unpaid portion and, within six months, complete a capital-change or transfer registration; the 2026 standards add the documents, including the written forfeiture notice and a resolution by the remaining shareholders with at least two-thirds of the voting rights. For loss-offsetting reduction, the standards add documents with the safeguard that the reduced amount may not exceed the paid-in capital in the credit-information system or shareholder register, and the change-registration date must follow the announcement. Ordinary reductions are simplified: where the announcement is already published via the credit-information system, the announcement material need not be resubmitted and the debt-settlement statement is dropped.

Bankruptcy acceleration of contribution

A distinct trigger operates outside the ordinary schedule. Enterprise Bankruptcy Law Article 35 provides that, after a court accepts a bankruptcy petition, where a shareholder has not fully performed the contribution obligation, the administrator may require payment of the subscribed capital in full, unrestricted by the original term — a statutory acceleration overriding any five-year or legacy schedule. In practice, administrators publish capital-recovery notices on the national enterprise bankruptcy restructuring information platform, demanding that shareholders pay subscribed-but-unpaid capital into the estate. These public notices neutrally show the term is no shield once insolvency begins.

Capital reduction procedure for foreign-invested enterprises

Where an entity reduces capital rather than pays up, the ordinary route needs a balance sheet and property list, a shareholders’ resolution, creditor notice and public announcement (newspaper or the credit-information system), then change registration; the new Company Law generally requires proportionate reduction unless the LLC shareholders otherwise agree or the joint-stock articles otherwise provide. For foreign-invested enterprises, reduction also meets the foreign-exchange side — a reduced capital-account inflow ceiling and any repatriation follow SAFE rules, and the investment-total field is captured in the 2026 form so a reduction pairs with the corresponding investment-total adjustment. Loss-offsetting and forfeiture-driven reductions use the special materials above rather than the ordinary creditor-notice package.

Practical checklist and common pitfalls

  1. Model the five-year schedule per entity. List each FIE, its incorporation date, subscription term and paid-in status; flag entities whose remaining term from 1 July 2027 exceeds five years, and compute the latest permissible payment date (no later than 30 June 2032) and the 30 June 2027 recording deadline.
  2. Decide the transition path early. For each flagged entity choose among adjusting the schedule to five years, completing the injection, or executing a capital reduction; amend the articles and the shareholder agreement before the deadline.
  3. Engineer the capital-remittance route. Confirm the overseas shareholder will remit in foreign exchange or cross-border RMB into the capital account; never use domestic funds to advance or substitute; coordinate the bank’s monetary-contribution recording so the funds become usable.
  4. Align the three ledgers. Keep the SAMR filing, the credit-information publicity and the SAFE registration figures consistent on subscribed and paid-in amounts; trigger the 20-working-day publicity after each contribution.
  5. Prepare for forfeiture and loss-offsetting scenarios. Where a shareholder cannot pay, follow the demand-and-grace procedure and, if forfeiture is triggered, complete the new-format capital-change registration within six months; for loss-making entities, assess a loss-offsetting reduction using the new materials.
  6. Keep the valuation and audit trail. Retain valuation reports and contribution records; for non-currency contributions, complete the title transfer and the foreign-exchange recording of the contribution type.

Common pitfalls: assuming the old open-ended term survives beyond 30 June 2027; treating intra-group renminbi as paid-in capital; letting the SAMR, credit-system and SAFE figures diverge; skipping the 20-working-day publicity; and overlooking that insolvency accelerates the obligation regardless of term.

Sources

  • 阳江市政府《中华人民共和国公司法(2023 修订)》: http://www.yangdong.gov.cn/yjydgaj/gkmlpt/content/0/810/post_810236.html
  • 中国政府网(法律法规/《公司法》): https://www.gov.cn/
  • 洪山区人民政府《经营主体登记文书规范和提交材料规范(2026 年版)》(国市监注发〔2026〕5 号): https://www.hongshan.gov.cn/gzfw/ztfw/qykb_85388/zctz_85390/202608/t20260825_2838574.shtml
  • 广西市场监管局《新版登记文书规范、材料规范解读》: http://scjdglj.gxzf.gov.cn/xwdt/qjdt/t27525843.shtml
  • 中国市场监管新闻网《登记管理新规范解读》: http://www.cmrnn.com.cn/content/2026-03/06/content_286402.html
  • 国家外汇管理局《深化跨境投融资外汇管理改革有关事宜》(汇发〔2025〕43 号)答记者问: http://m.safe.gov.cn/safe/2025/0915/26537.html
  • 国家外汇管理局: https://www.safe.gov.cn/
  • 全国企业破产重整案件信息网: https://pccz.court.gov.cn/

外商投资企业的注册资本认缴与出资期限管理(2026 年口径)

概述

注册资本制度是外国投资者在华设立企业时作出的第一项资本决策。2026 年它处于新《公司法》、国务院注册资本登记管理制度规定与市场监管登记申报标准的交汇点。五年实缴期限取代旧有无限期认缴模式;焦点是 2027 年 6 月 30 日——此前设立且剩余认缴期限自 2027 年 7 月 1 日起超五年的公司,须压缩至五年以内并记载于章程。本文说明该截止日、2026 年申报变化、外资外汇维度、破产加速与减资程序,并给出实操清单。

五年认缴规则与 2027 年过渡期

依修订后的《公司法》,有限责任公司的注册资本为全体股东认缴的出资额,全体股东须自公司成立之日起五年内缴足认缴出资;股份有限公司发起人须于成立前全额缴纳认购股份。

对 2024 年 7 月 1 日前设立的公司——含绝大多数既有外资企业——国务院规定给出过渡规则:剩余认缴期限自 2027 年 7 月 1 日起超五年的,须于 2027 年 6 月 30 日前调整至五年以内并记载于章程,股东于调整后期限内缴足。涉及国家利益或重大公共利益者,市场监管部门可批准原期限;期限或出资额明显异常者,可经评估要求调整。

合规日历比原则更重要。2019 年设立、旧章程约定 30 年认缴期的外商独资企业——2024 年前属常规——现面临强制节点。计算机械:自 2027 年 7 月 1 日起算至原到期日,跨度超五年则压缩剩余期限,使缴付最迟不晚于 2032 年 6 月 30 日,且调整须于 2027 年 6 月 30 日前记载。

出资方式与外资特有事项

出资方式菜单宽泛:货币、实物、知识产权、土地使用权、股权、债权,及法律有规定的数据、网络虚拟财产,均须评估作价。外资企业三特殊点:资本来源——认缴外资汇入外汇局资本金账户,由境外股东以现汇或跨境人民币汇入,不得以境内资金垫资充抵,集团误将境内人民币当实缴是常见错误;外汇衔接——市场监管、信用公示与外汇登记的认缴实缴金额须一致,货币出资收讫后办入账登记方可使用,非货币须评估并转移财产权、外汇侧据类型记录;验资留痕——保存评估报告、出资记录及注资凭证,2026 版标准以逐股东出资期限采集与实名确认表强化。

2026 年版登记文书与材料规范

市场监管总局 2026 年版登记文书与提交材料规范(国市监注发〔2026〕5 号,2026 年 5 月 1 日施行)将新《公司法》转译为登记机关文书。规范将设立登记”出资日期”改为”出资期限”,逐笔载明认缴额、方式与缴付起止日期,为催缴与失权建数据基础;将股东名册列为资本与股东变更、出资信息备案材料,落实以名册主张股东权利。两类新场景有专门材料:股东失权——经书面催缴并宽限期后仍不缴付的,可失权未缴部分并于六个月内办减资(或转让)登记,2026 版补充含书面失权通知及失权股权外代表剩余三分之二以上表决权股东决议等材料;弥补亏损减资——新增变更登记材料,设安全边界(减资额不超公示系统或名册实缴额,且变更登记日期晚于公告)。普通减资简化:已公示系统公告者免交公告材料,并不再收债务清偿或担保说明。

破产情形的出资加速到期

另一触发机制在常规排期之外运作。《企业破产法》第三十五条规定,人民法院受理破产申请后,股东尚未完全履行出资义务的,管理人应当要求缴纳所认缴出资,不受出资期限限制——这是凌驾于章程五年或存量长周期的法定加速。实务中,管理人通过全国企业破产重整案件信息网发布追缴出资公告,要求股东将已认缴未实缴资本缴入破产财产。这些公告中性地说明:进入破产程序后,认缴期限不再构成盾牌。

外资企业的减资程序

选择减资而非实缴的,普通路径须编制资产负债表及财产清单、作出股东会决议、通知债权人并公告,再办理变更登记;新《公司法》一般要求同比减资。对外资企业,减资还与外汇侧相交:调减后的资本金账户流入上限及任何资本汇出须遵循外汇局规则;2026 版表单采集投资总额字段,使减资与相应投资总额调整配对。弥补亏损减资与失权减资适用上述专门材料而非普通债权人通知包。

实操清单与常见误区

  1. 逐实体测五年排期:列明每家外资企业设立日、认缴期限与实缴状态,标记剩余期限自 2027 年 7 月 1 日起超五年者,算最迟缴付日(不晚于 2032 年 6 月 30 日)与 2027 年 6 月 30 日记载截止日。
  2. 早定过渡路径:被标记实体择”调至五年、完成注资、执行减资”之一,截止日前修订章程与股东协议。
  3. 设计出资汇入路径:境外股东现汇或跨境人民币汇入资本金账户,禁境内垫资,协调银行入账登记使资金可用。
  4. 对齐三套账:市场监管、信用公示、外汇登记金额一致,每次出资后触发 20 个工作日公示。
  5. 预备失权与补亏:股东无力缴付走催缴加宽限期,触发失权者六个月内核资本变更;亏损实体评估弥补亏损减资。
  6. 留存评估审计凭证:保存评估报告与出资记录,非货币出资办结转移及外汇侧类型记录。

常见误区:旧无限期期限可活过 2027 年 6 月 30 日;境内人民币当实缴;三方金额脱节;漏 20 个工作日公示;忽视破产加速义务。

来源

  • 阳江市政府《中华人民共和国公司法(2023 修订)》:http://www.yangdong.gov.cn/yjydgaj/gkmlpt/content/0/810/post_810236.html
  • 中国政府网(法律法规/《公司法》):https://www.gov.cn/
  • 洪山区人民政府《经营主体登记文书规范和提交材料规范(2026 年版)》(国市监注发〔2026〕5 号):https://www.hongshan.gov.cn/gzfw/ztfw/qykb_85388/zctz_85390/202608/t20260825_2838574.shtml
  • 广西市场监管局《新版登记文书规范、材料规范解读》:http://scjdglj.gxzf.gov.cn/xwdt/qjdt/t27525843.shtml
  • 中国市场监管新闻网《登记管理新规范解读》:http://www.cmrnn.com.cn/content/2026-03/06/content_286402.html
  • 国家外汇管理局《深化跨境投融资外汇管理改革有关事宜》(汇发〔2025〕43 号)答记者问:http://m.safe.gov.cn/safe/2025/0915/26537.html
  • 国家外汇管理局:https://www.safe.gov.cn/
  • 全国企业破产重整案件信息网:https://pccz.court.gov.cn/

Pharma and biotech opening moves from the foreign-investment action plan: segmented production, pilot expansion and the payment chain

  • The Action Plan for Stabilising and Optimising the Utilisation of Foreign Investment (商资发〔2026〕97号, issued 16 June 2026 by MOFCOM, NDRC and MOF) commits the government to “expedite the study and issuance of implementation rules for segmented pharmaceutical production”, easing cross-border segmented manufacturing of biologics and chemical drugs by foreign marketing-authorisation holders.
    商务部、国家发展改革委、财政部《利用外资固稳促优行动方案》(商资发〔2026〕97号,2026年6月16日印发)明确”抓紧研究出台药品分段生产实施细则”,便利境外药品上市许可持有人开展生物制品、化学药品跨境分段生产。
  • The same plan moves to widen pilot geography: authorities will “expedite research and approval to further expand the pilot regions for biotechnology and wholly foreign-owned hospitals” — the two most-watched restricted-service openings of the current cycle.
    同一方案还推动试点扩围:”抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围”——这是本轮最受关注的两项限制性服务业开放。
  • The statutory base is already in place: the revised Drug Administration Law Implementation Regulations (published January 2026) turned segmented production from pilot into institution, letting marketing-authorisation holders commission qualified producers to segment-manufacture innovative drugs and clinically urgent drugs when genuinely needed, under a unified quality-assurance system covering all sites.
    法定底座已经就位:修订后的《药品管理法实施条例》(2026年1月公布)把分段生产从试点推向制度——药品上市许可持有人确有需要的,可委托符合条件的企业分段生产创新药、临床急需药品等,并建立覆盖全部生产场地的统一质量保证体系。
  • Commercial proof-of-concept has landed: in May 2026 Johnson & Johnson’s niccalimab injection became the first imported biologic to run domestic segmented production of drug substance in China, with the substance made by WuXi Bio in Wuxi and fill-finish completed in Germany.
    商业验证已经落地:2026年5月,强生制药的尼卡利单抗注射液成为全国首个开展原液境内分段生产的进口生物制品——原液由无锡药明生物生产,制剂在德国完成。
  • Biotech opening pilots are producing registrable outcomes: under the 2024 pilot allowing FIEs to develop and apply human stem-cell and gene diagnosis and therapy technologies in designated free trade zones, at least six foreign companies — including Merck, JW Therapeutics-related entities, Frontera Therapeutics and StarCellBio — have completed registration changes or new filings.
    生物技术开放试点已产出可登记成果:在2024年允许外商投资企业于指定自贸区开展人体干细胞、基因诊断与治疗技术开发应用的试点下,至少6家外资企业(含默克、药明巨诺相关主体、芳拓生物、星奕昂等)已完成经营范围变更或新设登记。
  • Payment and channel measures complete the chain: the plan supports insurers in covering more innovative drugs and devices under commercial health insurance, and calls for an industry collaboration platform to smooth foreign-made pharmaceuticals into retail channels — the “last mile” that has capped foreign pharma revenue in China.
    支付与渠道措施补齐链条:方案支持保险公司将更多创新药械纳入商业保险保障范围,并搭建行业协作平台便利外资企业生产的药品进入零售渠道——这正是此前封顶外资药企中国收入的”最后一公里”。

Pharma and biotech opening moves from the foreign-investment action plan: segmented production, pilot expansion and the payment chain | 外资行动方案中的医药开放组合:分段生产、试点扩围与支付渠道

Overview

The Action Plan for Stabilising and Optimising the Utilisation of Foreign Investment (《利用外资固稳促优行动方案》, 商资发〔2026〕97号), issued on 16 June 2026 by the Ministry of Commerce, the National Development and Reform Commission and the Ministry of Finance with State Council consent, devotes one of its fifteen measures to pharmaceuticals. The measure assembles a “production — marketing-authorisation — payment — channel” package for foreign pharmaceutical and biotech companies: segmented production implementation rules, expanded pilot geography for biotechnology and wholly foreign-owned hospitals, commercial-insurance payment support, and retail-channel facilitation.

With September 2026 commentary from the Shanghai government’s weekly foreign-invested information service now tracking the package in detail, the measures are the clearest single statement of where foreign pharma market access in China is heading this cycle.

Segmented production: from pilot to statute to rules

Segmented production (分段生产) distributes a drug’s manufacturing process across sites or companies — globally common, but long restricted in China. The progression:

  • October 2024: the National Medical Products Administration issued the pilot work plan for segmented production of biologics, allowing certain innovative and clinically urgent biologics to run segmented production at the pilot stage.
  • January 2026: the State Council published the revised Drug Administration Law Implementation Regulations, moving segmented production into institution. Article 31 provides that where a marketing-authorisation holder genuinely needs it, the holder may commission qualified manufacturers to segment-manufacture (i) innovative drugs with special process, facility or equipment requirements, (ii) clinically urgent drugs and drugs needed for public-health response or reserves identified by the State Council departments, and (iii) other drugs specified by the drug regulator. The holder must build a unified quality-assurance system covering the whole production process and all sites; vaccines and blood products carry their own commissioning rules.
  • Next step: the action plan’s commitment to issue implementation rules for segmented pharmaceutical production — the operational layer for application conditions, quality-responsibility allocation and regulatory coordination.

The commercial template already exists: in May 2026, Johnson & Johnson’s niccalimab injection became the first imported biologic to run domestic segmented production of drug substance — substance produced by WuXi Biologics in Wuxi, fill-finish completed by Vetter Pharma in Germany. For multinationals, the case demonstrates the operating model the rules will generalise: foreign marketing-authorisation holders placing upstream segments with qualified Chinese CDMOs while keeping downstream finishing abroad, or the reverse.

Biotechnology and wholly foreign-owned hospitals: pilot expansion pending approval

Biotechnology (human stem cells, gene diagnosis and therapy) has been open to FIEs only inside designated pilot areas since September 2024, when Beijing, Shanghai and Guangdong free trade zones and Hainan were authorised. The registry shows results: at least six foreign companies — including Merck, entities associated with JW Therapeutics (药明巨诺), Frontera Therapeutics (芳拓生物) and StarCellBio (星奕昂) — have completed business-scope changes or new registrations inside the pilot areas.

The action plan instructs authorities to expedite research and approval for expanding the pilot regions for both biotechnology and wholly foreign-owned hospitals — the same two openings that Shanghai’s 15th Five-Year plan and other provincial documents name as landing priorities. Neither expansion has been formally approved yet; the plan converts the expansion from discussion item into an official workstream with a deadline pressure attached.

Payment and channels: the last-mile package

Two measures address the revenue side that has historically capped foreign pharma’s China performance:

  • Commercial insurance. The plan supports insurers in bringing more innovative drugs and devices into commercial health-insurance coverage — the payer channel that has grown fastest as national reimbursement negotiations compress prices.
  • Retail channels. An industry collaboration platform will be built to facilitate foreign-produced pharmaceuticals entering drug retail channels — addressing the distribution friction that has kept foreign-manufactured drugs out of pharmacy chains even after approval.

What this means for foreign pharma and healthcare groups

  • Map your product portfolio against segmented-production eligibility. The statutory categories are innovative drugs with special process/equipment requirements and clinically urgent or reserve drugs; groups with biologics or special-technology chemicals should identify candidates and pre-qualify Chinese CDMO partners under a unified quality system.
  • Watch the implementation rules, not just the plan. Application conditions, quality-responsibility division and regulatory coordination sit in the forthcoming rules; the drafting is the moment to submit practical comments.
  • Treat pilot expansion as a siting decision. If the biotech and wholly-owned-hospital pilots extend to new provinces, entity location inside a pilot area becomes a structuring variable; hold new China healthcare investments until the expanded map is published.
  • Build the commercial-insurance and retail strategy now. Payment support and retail-channel facilitation are revenue-side measures; groups that prepare health-insurance dossiers and pharmacy distribution agreements can move when the platforms land.
  • Benchmark against the niccalimab case. The first segmented-production precedent defines the documentation and quality-system expectations regulators will apply to the next applications.

Sources

  • 济源产城融合示范区管理委员会(转载)— 商务部 国家发展改革委 财政部关于印发《利用外资固稳促优行动方案》的通知(商资发〔2026〕97号,2026年6月16日,政府官网全文): https://zt.www.jiyuan.gov.cn/zsyz/wstz_zsyz/zcfb/t1008712.html
  • 上海市人民政府外事办公室 — 《上海资讯周报》涉外资讯一站式服务(2026年9月第1期,总第157期,2026年9月2日,医药开放组合与分段生产制度演进综述): https://wsb.sh.gov.cn/ztzl/shzxzb/20260902/d2eb54ce238e4d6d9f5bcac6e428f6e6.html
  • 蒙城县人民政府(转载)— 中华人民共和国药品管理法实施条例(2026年修订版分段生产条款第31—33条全文): https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

Related reading

  • see also: segmented pharma production pilot mechanics (segmented-pharma-production)
  • see also: wholly foreign-owned hospital pilot requirements (foreign-owned-hospital-pilot)

外资行动方案中的医药开放组合:分段生产、试点扩围与支付渠道

概述

《利用外资固稳促优行动方案》(商资发〔2026〕97号)由商务部、国家发展改革委、财政部经国务院同意于2026年6月16日印发,其十五条举措中专设一条指向医药。该条为外资医药与生物技术企业组装了一套”生产—上市许可—支付—渠道”组合:分段生产实施细则、生物技术与外商独资医院试点扩围、商业保险支付支持与零售渠道便利。

随着2026年9月上海市政府涉外资讯周报对该政策包作出详细追踪解读,这是本周期内中国外资药品准入走向最清晰的一份单项表述。

分段生产:从试点到法定再到细则

分段生产(分段生产)把药品生产过程分布在不同场地或企业之间——全球通行,但在中国长期受限。演进脉络:

  • 2024年10月: 国家药监局印发生物制品分段生产试点工作方案,允许部分创新生物制品和临床急需生物制品在试点阶段开展分段生产。
  • 2026年1月: 国务院公布修订后的《药品管理法实施条例》,把分段生产推向制度。第三十一条规定,药品上市许可持有人确有需要的,可以委托符合条件的药品生产企业分段生产:(一)生产工艺、设施设备有特殊要求的创新药;(二)临床急需药品、应对突发公共卫生事件急需或储备需要的药品;(三)国务院药品监督管理部门规定的其他药品。持有人须建立覆盖药品生产全过程和全部生产场地的统一质量保证体系;疫苗、血液制品另有委托生产规则。
  • 下一步: 行动方案承诺出台药品分段生产实施细则——即申请条件、质量责任划分与监管协调的操作层。

商业模板已经出现:2026年5月,强生制药的尼卡利单抗注射液成为全国首个开展原液境内分段生产的进口生物制品——原液由无锡药明生物生产,制剂由德国Vetter Pharma完成。对跨国药企而言,该案例演示了细则将要推广的运营模式:境外持有人把上游环节放在中国合格CDMO、下游制剂留在境外,或反向操作。

生物技术与外商独资医院:扩围报批中

自2024年9月北京、上海、广东自贸区和海南获准试点以来,生物技术(人体干细胞、基因诊断与治疗)仅对试点区域内FIE开放。登记情况已有产出:至少6家外资企业——包括默克、药明巨诺相关主体、芳拓生物(Frontera Therapeutics)、星奕昂等——已在试点区域内完成经营范围变更或新设登记。

行动方案要求抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围——上海”十五五”规划等省级文件点名的同样是这两项开放。扩围尚未正式获批;方案把扩围从讨论事项转为带时限压力的正式工作流程。

支付与渠道:最后一公里

两项措施指向历史上封顶外资药企中国收入的收入端:

  • 商业保险。 方案支持保险公司将更多创新药械纳入商业健康保险保障范围——在国家谈判压缩价格背景下增长最快的支付通道。
  • 零售渠道。 将搭建行业协作平台,便利外资企业生产的药品进入药品零售渠道——解决获批外资药品难以进入连锁药店的流通摩擦。

对外资医药与医疗集团的启示

  • 对照分段生产法定情形梳理产品组合。 法定类别是工艺设施有特殊要求的创新药与临床急需、储备药品;拥有生物制品或特殊工艺化学药的企业应识别候选产品,并按统一质量体系预审中国CDMO伙伴。
  • 盯细则而不止于方案。 申请条件、质量责任划分与监管协调都在即将出台的实施细则中;起草阶段是提交实务意见的窗口。
  • 把试点扩围当作选址变量。 若生物技术与独资医院试点扩展至新省份,主体落位在试点区域内就成为架构变量;新医疗投资可等扩围地图公布后再定。
  • 现在就建商保与零售策略。 支付支持与渠道便利是收入端措施;提前准备健康险材料与药店分销协议的集团,可在平台落地时立即行动。
  • 对标尼卡利单抗案例。 首个分段生产先例界定了监管对后续申请的单证与质量体系预期。

来源

  • 济源产城融合示范区管理委员会(转载)— 《利用外资固稳促优行动方案》通知全文(商资发〔2026〕97号): https://zt.www.jiyuan.gov.cn/zsyz/wstz_zsyz/zcfb/t1008712.html
  • 上海市人民政府外事办公室 — 《上海资讯周报》涉外资讯一站式服务(2026年9月第1期): https://wsb.sh.gov.cn/ztzl/shzxzb/20260902/d2eb54ce238e4d6d9f5bcac6e428f6e6.html
  • 蒙城县人民政府(转载)— 中华人民共和国药品管理法实施条例(分段生产条款全文): https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

相关阅读

  • 见:药品分段生产试点机制要点(segmented-pharma-production)
  • 见:外商独资医院试点要求(foreign-owned-hospital-pilot)

China extends self-printed preferential origin certificates to Myanmar and Cambodia shipments from 16 September 2026

  • GACC Announcement No. 135 (2026), issued on 7 September 2026, extends self-printable preferential origin certificates from 16 September 2026 to shipments to Myanmar and Cambodia under the RCEP and the China–ASEAN FTA framework, and to Cambodia under the China–Cambodia FTA, moving a further tranche of certificate issuance fully online.
    海关总署公告2026年第135号(2026年9月7日发布)决定自2026年9月16日起,将《区域全面经济伙伴关系协定》(RCEP)和《中华人民共和国与东南亚国家联盟全面经济合作框架协议》项下输缅甸、柬埔寨,以及《中华人民共和国政府和柬埔寨王国政府自由贸易协定》项下输柬埔寨的原产地证书,增加为可自助打印证书,推动又一批证书签发全面线上化。
  • Self-printing lets exporters print approved preferential origin certificates on A4 paper at their own premises through the China International Trade Single Window or the customs government-service platform, eliminating a physical visit to a customs office to collect the stamped paper.
    自助打印是指出口企业通过中国国际贸易”单一窗口”或海关政务服务平台,在审核通过后自行使用彩色打印设备在A4纸上打印带有底纹、企业签章及签名、海关签章及签名的原产地证书,无需再到海关现场领取纸质证书。
  • The extension follows the consolidation of customs electronic-document rules: alongside electronic certificates, e-declarations and e-inspection documents now carry the same legal effect as paper versions, and all previous separate CIIE-related notices were repealed by Announcement No. 128 in the same week.
    此次扩围与海关电子单证规则整合同步推进:电子报关单证、原产地证书与检验检疫电子单证与纸质文件具有同等法律效力;同一周发布的第128号公告亦废止了此前历届进博会通关便利化文件。
  • For foreign-invested exporters and trading companies operating in China, the practical gain is speed and cost: certificate data is transmitted electronically to the importing customs, supporting paperless declaration and tariff preference claims for consignments to the two Southeast Asian markets.
    对在华经营的外资出口企业和贸易公司而言,实际收益在于速度与成本:证书电子数据直通进口方海关,支持对缅甸、柬埔寨两市场的无纸化申报与关税优惠申请。
  • Background momentum: electronic exchange of origin data with Malaysia began on 1 June 2026 under GACC Announcement No. 74, with full electronic-only processing from 1 December 2026 — Myanmar and Cambodia expansion follows the same digital-first trajectory.
    背景动能:根据海关总署公告2026年第74号,中国—马来西亚原产地电子信息交换系统已于2026年6月1日运行,2026年12月1日起全面实行电子联网模式——此次缅甸、柬埔寨扩围延续同一数字化优先路径。
  • Compliance note: the self-printing mechanics follow GACC Announcement No. 77 (2019) on the general rollout of self-printed origin certificates; enterprises should confirm they hold an approved seal-and-signature authorisation in the system before the new routes go live on 16 September.
    合规提示:自助打印的操作规则沿用海关总署2019年第77号公告(关于全面推广原产地证书自助打印的公告);企业应在9月16日新线路启用前,确认已在系统中完成印章、签名的授权备案。

China extends self-printed preferential origin certificates to Myanmar and Cambodia shipments from 16 September 2026 | 海关总署再扩自助打印”朋友圈”:输缅甸、柬埔寨优惠原产地证书9月16日起可自助打印

Overview

On 7 September 2026, the General Administration of Customs of China (GACC) issued Announcement No. 135 (2026), deciding that from 16 September 2026 the list of self-printable preferential origin certificates will be expanded. The newly included certificates cover shipments to Myanmar and Cambodia under the Regional Comprehensive Economic Partnership (RCEP) and under the framework agreement on comprehensive economic cooperation between China and ASEAN, plus shipments to Cambodia under the China–Cambodia Free Trade Agreement. Other matters continue to follow GACC Announcement No. 77 (2019) on the general rollout of self-printed origin certificates.

The announcement is short, but it sits inside a fast-moving digitisation of China’s origin-certificate administration. For foreign-invested exporters and trading houses that route goods to Southeast Asia from mainland production or procurement bases, the change removes a remaining paper step and aligns Myanmar- and Cambodia-bound consignments with the paperless channels already available for many other destinations.

What “self-printing” means in practice

Since GACC promoted self-printed origin certificates nationwide in 2019, an exporter whose certificate application has been approved by customs can print the certificate itself on plain A4 paper with a colour printer, instead of visiting a customs office to collect a stamped copy. The printed sheet carries the security background, the enterprise’s own seal and signature, and the customs seal and signature. The exporter first completes a one-off authorisation of its seal and authorised signatories in the system; once approved, printing is done from the applicant’s own terminal.

The practical consequences are well established: shorter lead times for certificate release, no travel to a customs counter, and full visibility of certificate status from the exporter’s own system. What changes on 16 September is simply the geographic coverage — certificates for the Myanmar and Cambodia corridors under the relevant preferential arrangements join the self-printable family.

Which certificates are added

Read carefully, the new coverage is threefold:

  1. certificates under RCEP for exports to Myanmar;
  2. certificates under the China–ASEAN comprehensive economic cooperation framework agreement for exports to Myanmar and Cambodia; and
  3. certificates under the China–Cambodia Free Trade Agreement for exports to Cambodia.

In other words, exporters claiming preferential tariff treatment on goods shipped from China to Myanmar or Cambodia under any of these three instruments can, from 16 September 2026, obtain the supporting origin certificate by self-printing rather than by visiting customs.

Why it matters for foreign-invested traders

For multinational groups that manufacture or trade out of China, tariff-preference documentation is a routine but high-stakes process. A certificate that is delayed or that carries a clerical error can hold a container at the border or forfeit a tariff margin that the commercial contract already priced in. Three features of this update matter:

  • Faster certificate issuance. Self-printing cuts the queue for counter collection and lets the exporter time the certificate to the shipment, which is valuable where buyers request certificates at short notice.
  • Lower administrative cost. Removing the need for a physical customs visit reduces the logistics of documentation for companies located away from a competent issuing office, and fits the operating pattern of trading companies that manage several origin regimes in parallel.
  • Cleaner e-record trail. Because self-printed certificates flow through the electronic system, the audit trail for AEO-style compliance reviews and for later verifications by importing customs is more straightforward.

The broader digitisation context

The 135th announcement is one of several recent moves that together redraw the paperwork map of China’s preferential trade:

  • Electronic exchange of origin data with Malaysia. Under GACC Announcement No. 74 (2026), the China–Malaysia electronic exchange system for origin information has operated since 1 June 2026, transmitting RCEP certificates, back-to-back certificates and China–ASEAN framework certificates in real time. During the transition to 30 November 2026, importers who receive a “no electronic data found” prompt may still key in the certificate information manually; from 1 December 2026, an importer wanting early release of goods without a matched e-record must apply for a duty guarantee instead.
  • Equal legal effect of electronic documents. With the September 2026 batch of trade facilitation rules, electronic customs declarations, origin certificates and inspection/quarantine e-documents carry the same legal force as their paper counterparts, which underpins paperless declaration at import.
  • Rolling consolidation of event-based notices. GACC Announcement No. 128 (2026) on the ninth China International Import Expo issued the 2026 customs clearance guide and facilitation measures and repealed eight earlier expo-related announcements, keeping the rulebook current in one place.

Seen together, these steps describe a single direction: origin certification in China is becoming an online, data-linked process in which the paper certificate is a print-out of an electronic record rather than a standalone document.

Practical steps

  • Confirm that your company’s seal and authorised-signatory details are registered and approved in the self-printing module of the China International Trade Single Window or the customs government-service platform before 16 September 2026.
  • Identify which of your current shipments to Myanmar and Cambodia claim preference under RCEP, the China–ASEAN framework agreement or the China–Cambodia FTA, and update your standard operating procedures so those certificate types are printed in-house from the effective date.
  • For imports into China from Malaysia, review whether your vendors’ certificates are reaching the electronic exchange system; where a shipment moves without matched electronic data after 1 December 2026, plan for the duty-guarantee route.
  • Keep a documented file of each self-printed certificate, including the electronic serial number, because importing customs in the destination market may verify origin through official channels.

Sources

  • 海关总署公告2026年第135号(关于增加输缅甸、柬埔寨自助打印优惠原产地证书的公告): http://www.customs.gov.cn/customs/2026-09/09/article_2026090911301668140.html
  • 长沙海关 — RCEP原产地应用场景式服务(自助打印、经核准出口商流程说明): http://changsha.customs.gov.cn/changsha_customs/ztzl/rcepycdzsqzcjsfw/index.html
  • 北京海关 — 原产地证书签发场景式服务(申请入口与流程): http://beijing.customs.gov.cn/ningbo_customs/470784/cjsfw53/ycdzmsqfcjsfw/index.html
  • 中国国际进口博览会官网 — 海关总署公告2026年第128号(进博会通关须知与便利措施): https://www.ciie.org/zbh/bqgffb/20260902/63841.html

Related reading

  • see also: RCEP origin certificate mutual recognition and electronic networking trends (rcep-certificate-mutual-recognition-2026)
  • see also: how foreign-invested companies use RCEP tariff concessions in 2026 (rcep-2026-tariff-concession-schedule)

海关总署再扩自助打印”朋友圈”:输缅甸、柬埔寨优惠原产地证书9月16日起可自助打印

概述

2026年9月7日,海关总署发布公告2026年第135号,决定自2026年9月16日起,扩大可自助打印的优惠原产地证书范围。新增范围包括:《区域全面经济伙伴关系协定》(RCEP)和《中华人民共和国与东南亚国家联盟全面经济合作框架协议》项下输往缅甸、柬埔寨,以及《中华人民共和国政府和柬埔寨王国政府自由贸易协定》项下输往柬埔寨的原产地证书。其他事项按海关总署2019年第77号公告(关于全面推广原产地证书自助打印的公告)执行。

公告本身很简短,但它处在海关原产地证书管理快速数字化的进程中。对于以中国大陆生产或采购基地向东南亚发货的外资出口企业与贸易公司而言,这一变化消除了最后一道线下领证环节,使输往缅甸、柬埔寨的货物与许多其他目的地已可用的无纸化通道对齐。

自助打印在实际操作中意味着什么

自2019年海关全面推广原产地证书自助打印以来,出口企业在证书申请经海关审核通过后,即可使用彩色打印设备在A4纸上自行打印证书,而无需再到海关现场领取盖章纸质证书。打印出的证书带有防伪底纹、企业签章及签名、海关签章及签名。企业需先在系统中完成印章与授权签字人的一次性备案;备案通过后,即可在自己终端打印。

实际效果早已被实践验证:缩短证书出证周期、免去柜台往返、企业系统内全程可视证书状态。9月16日发生变化的只是地域覆盖——相关优惠安排项下缅甸、柬埔寨通道的证书加入可自助打印行列。

新增了哪些证书

仔细解读,新覆盖分三层:

  1. RCEP项下输往缅甸的证书;
  2. 中国—东盟全面经济合作框架协议项下输往缅甸和柬埔寨的证书;
  3. 中柬自贸协定项下输往柬埔寨的证书。

换言之,凡按上述三项安排之一、从中国出口至缅甸或柬埔寨并主张优惠关税待遇的出口企业,自2026年9月16日起即可自助打印所凭原产地证书,无需再跑海关。

对在华外资贸易企业为何重要

对以中国为制造或贸易基地的跨国集团而言,关税优惠单证是常规但高风险的流程环节。证书延误或差错,可能让货柜滞留口岸,或使商业合同已计入价格的关税优惠落空。本次更新的三个要点:

  • 出证更快。 自助打印省去柜台排队,企业可把证书时间与船期精确对齐,对买方临时要证的场景尤其宝贵。
  • 行政成本更低。 免去现场领证的往返,对办公地点距签证机构较远、且并行管理多个原产地制度的企业更为友好。
  • 电子留痕更清晰。 自助打印证书全程走电子系统,便于AEO式合规复核及进口方海关后续核查留取审计轨迹。

更宏观的数字化背景

第135号公告是近期一系列举措之一,共同重塑中国优惠贸易单证版图:

  • 与马来西亚实现原产地数据电子交换。 依据海关总署公告2026年第74号,中马原产地电子信息交换系统自2026年6月1日起运行,实时传输RCEP证书、背对背证书与中国—东盟框架证书。2026年11月30日前的过渡期内,进口人遇”无法查找到原产地证明电子数据”提示的,仍可手动录入证书电子信息;自2026年12月1日起,进口人在无电子数据匹配的情况下要求提前放行货物的,应申请办理税款担保。
  • 电子单证具有同等法律效力。 随着2026年9月一批贸易便利化规则落地,电子报关单证、原产地证书与检验检疫电子单证与纸质文件具有同等法律效力,为进口无纸化申报奠定基础。
  • 展会类公告滚动整合。 海关总署公告2026年第128号就第九届进博会发布2026年通关须知与便利措施,同时废止此前八份进博会相关公告,使规则体系统一更新。

综合来看,这些步骤指向同一方向:中国的原产地签证正走向在线化、数据互联,纸质证书成为电子记录的打印件,而不再是独立单证。

实务建议

  • 在2026年9月16日前,确认公司印章与授权签字人信息已在中国国际贸易”单一窗口”或海关政务服务平台的印章签名授权模块完成备案。
  • 梳理当前输往缅甸、柬埔寨的哪些货批分别按RCEP、中国—东盟框架协定或中柬自贸协定主张优惠,并更新作业规程,使相关证书类型自生效日起改为自助打印。
  • 从马来西亚进口的,核查境外供应商证书是否已进入电子交换系统;2026年12月1日之后如货物无电子数据匹配,应预判税款担保路径。
  • 妥善留存每份自助打印证书档案,包括电子编号,因目的地国进口海关可能通过官方渠道开展原产地核查。

来源

  • 海关总署公告2026年第135号(关于增加输缅甸、柬埔寨自助打印优惠原产地证书的公告): http://www.customs.gov.cn/customs/2026-09/09/article_2026090911301668140.html
  • 长沙海关 — RCEP原产地应用场景式服务(自助打印、经核准出口商流程说明): http://changsha.customs.gov.cn/changsha_customs/ztzl/rcepycdzsqzcjsfw/index.html
  • 北京海关 — 原产地证书签发场景式服务(申请入口与流程): http://beijing.customs.gov.cn/ningbo_customs/470784/cjsfw53/ycdzmsqfcjsfw/index.html
  • 中国国际进口博览会官网 — 海关总署公告2026年第128号(进博会通关须知与便利措施): https://www.ciie.org/zbh/bqgffb/20260902/63841.html

相关阅读

  • 见:RCEP原产地证书互认与电子联网趋势(rcep-certificate-mutual-recognition-2026)
  • 见:2026年外资企业如何运用RCEP关税减让(rcep-2026-tariff-concession-schedule)

Keeping profits invested in China: the domestic-reinvestment framework and Chongqing’s 2026 implementation

  • China’s framework encouraging reinvestment in China by foreign-invested enterprises took concrete local form on 4 September 2026, when Chongqing issued 16 measures (Yu Fagai Guifan [2026] No. 9) implementing the national policy set out in the NDRC-led 2025 notice (Fa Gai Wai Zi [2025] No. 928) on encouraging domestic reinvestment by foreign-invested enterprises.
    中国鼓励外商投资企业境内再投资的制度框架于2026年9月4日落地为具体地方政策:重庆印发16条措施(渝发改规范〔2026〕9号),落实国家发展改革委等部门2025年《关于实施鼓励外商投资企业境内再投资若干措施的通知》(发改外资〔2025〕928号)确立的国家政策。
  • Reinvestment means an FIE in China using its undistributed profits, or an overseas investor using profits lawfully derived in China, to set up a new enterprise, increase capital in an existing one, acquire equity or other interests, or fund investment projects — a channel that keeps foreign capital working inside China rather than repatriating it.
    再投资是指外商投资企业运用未分配利润、或境外投资者以境内合法分得的本外币利润,在境内投资新设企业、增资现有企业、取得境内企业股份股权财产份额或其他类似权益、以及投资项目——让外资留在境内继续经营而非汇出。
  • The 2025 national notice delivered eleven measures: project-service guarantees with access to key-foreign-project lists, land-allocation flexibility, streamlined procedures for new reinvestment entities, easier use of foreign-exchange profits (domestic transfers of lawful FX profits), financing channels (green-channel treatment for related-shareholder loans and panda bonds), and financial product innovation.
    2025年国家通知提出11项措施:项目服务保障(符合条件的再投资项目可纳入重大和重点外资项目清单)、优化土地要素配置、简化再投资新设企业办理流程、便利外汇资金使用(合法外汇利润可按规定境内划转)、畅通融资渠道(外方关联股东贷款、”熊猫债”纳入”绿色通道”管理)以及金融产品与服务创新。
  • Chongqing’s 16 measures steer reinvestment toward its manufacturing clusters (“33618”), modern services (“9611”) and technology strategy (“416”), applying national-treatment principles — full removal of manufacturing FDI access restrictions is confirmed, with reinvesting projects eligible for the same factor guarantees and support policies as domestic projects.
    重庆16条把再投资引向其制造业集群(”33618″)、现代服务业(”9611″)与科技创新布局(”416″),落实内外资一致原则——确认制造业外资准入限制”全面清零”,符合条件的外资再投资制造业项目按内外资一致原则同等享受要素保障与扶持政策。
  • Practical financial facilitation in Chongqing includes panda-bond issuance support, delegation of the signing-and-registration authority for related-shareholder loans, QFLP pilot exploration, removal of account-opening requirements for renminbi reinvestment of capital-project income and domestic profit, and streamlined bank FX procedures — lowering the friction of keeping profits invested.
    重庆的金融便利化细则包括:支持发行”熊猫债”、下放外方关联股东贷款签约登记权限、探索QFLP试点、取消资本项目人民币收入与境内人民币利润再投资对应的账户开立要求、鼓励银行优化外汇业务流程——降低利润留华再投资的摩擦。
  • For overseas investors, the practical takeaways are: profit reinvestment now enjoys explicit service guarantees and financing facilitation at national and local levels; reinvestment-oriented enterprises should review the profit-reinvestment tax preference rules, the information-reporting pilot for domestic investment, and the sector maps of the relevant province before structuring the deal.
    对境外投资者的实务要点:利润再投资在国家与地方层面均获得明确的服务保障与融资便利;筹划交易前应了解利润再投资税收优惠政策、境内投资信息报告试点以及所在省份的产业引导方向。

Keeping profits invested in China: the domestic-reinvestment framework and Chongqing’s 2026 implementation | 让利润留在中国:外资境内再投资框架与重庆2026版落地16条

Overview

Encouraging foreign-invested enterprises (FIEs) and their overseas shareholders to reinvest profits inside China rather than repatriate them has been a declared policy priority for three consecutive years of the government work report. The national architecture rests on the notice issued in July 2025 by the National Development and Reform Commission (NDRC) together with six other departments — the Notice on Implementing Measures to Encourage Domestic Reinvestment by Foreign-Invested Enterprises (Fa Gai Wai Zi [2025] No. 928) — which set out eleven facilitation measures.

The framework moved from national guidance to local operation in September 2026. On 4 September 2026 the Chongqing Development and Reform Commission issued the Measures of Chongqing Municipality on Encouraging Domestic Reinvestment by Foreign-Invested Enterprises (Yu Fagai Guifan [2026] No. 9), a 16-measure package that translates the national policy into concrete sector targeting, financial facilitation and service guarantees. Chongqing is one of the first large municipalities to publish a dedicated implementation, and its measures are a useful lens for any FIE group assessing where and how to keep profits invested in China.

What “reinvestment” covers

Under both the national notice and the Chongqing measures, reinvestment includes: an FIE established in China using its undistributed profits, or an overseas investor using profits lawfully derived in China (in RMB or foreign currency), to:

  • establish a new enterprise;
  • increase the capital of an existing enterprise;
  • acquire shares, equity interests, property shares or similar interests in a domestic enterprise; or
  • fund investment projects.

The definition is broad enough to cover organic expansion, M&A-style investments and project financing — the main routes by which foreign capital deepens rather than exits.

The national framework: eleven measures

The 2025 NDRC-led notice rests on four pillars:

  • Project service guarantees. Reinvestment projects that meet the criteria can be included in the lists of major and key foreign-investment projects and enjoy the corresponding support policies, giving them access to the tiered project-service machinery.
  • Land allocation. Optimised allocation of land factors for reinvestment, including flexible supply models.
  • Simplified procedures. Streamlined procedures for establishing a new enterprise for reinvestment purposes.
  • Foreign-exchange and financing facilitation. Foreign-exchange profits lawfully derived can be transferred domestically in accordance with the rules for reinvestment; financing channels are widened, with related-shareholder loans from the foreign side and panda bonds brought under “green channel” management.

The tax layer sits alongside the notice: under the rules on profit-reinvestment tax treatment applicable to foreign investors who directly invest their distributed profits in China, qualifying reinvestment can defer or credit the withholding exposure that would otherwise arise on dividend distribution — investors should confirm the current implementing details with their advisers, as the regime was refined through 2025 announcements.

Chongqing’s 16 measures: sector targeting meets national treatment

Chongqing’s implementation organises 16 measures into three dimensions — guiding investment direction, facilitating investment and operation, and raising service guarantees — with national treatment as the spine:

  • Direction. Reinvestment is guided toward the “33618” modern-manufacturing cluster system (intelligent connected new-energy vehicles, new-generation electronic information manufacturing, advanced materials and related tracks), the “9611” modern-services system (industrial design, supply-chain management, IP operation, brand marketing, inspection and certification), and the “416” science-and-technology strategy (R&D centres, technology-attack projects, pilot-platform construction). The municipality confirms that manufacturing FDI access restrictions have been fully removed (“全面清零”) and that qualifying reinvestment projects in manufacturing enjoy the same factor guarantees and support policies as domestic projects under the national-treatment principle.
  • Financial facilitation. Enterprises are supported in issuing panda bonds; the signing-and-registration authority for foreign related-shareholder loans is delegated downward; QFLP pilots are explored; the requirement to open dedicated accounts for renminbi reinvestment of capital-project income and domestic renminbi profits is cancelled; and banks are encouraged to streamline foreign-exchange business procedures. The municipality also supports reinvestment projects in applying for ultra-long-term special treasury bond funds and encourages the expansion of Chongqing entries in the Catalogue of Industries with Advantages for Foreign Investment in Central and Western China, linking to the encouraged-industry tax incentives.
  • Service guarantees. A municipal reinvestment project bank is established with tiered co-ordination by foreign-investment project teams; the business-environment regulation is to be revised to raise the ease of living and working in Chongqing for foreign nationals; a pilot on information reporting of domestic investment by FIEs is advanced with cross-departmental data sharing; and the performance-evaluation system for investment promotion will count domestic reinvestment.

What this means for foreign-invested groups

  • Reinvestment is now a managed, service-backed channel. Between the national project-list machinery and local project banks, a reinvestment that fits the province’s sector map can expect faster co-ordination than an ad-hoc expansion.
  • Sector maps differ by province. Chongqing’s “33618/9611/416” vocabulary is local; the same logic — steer reinvestment toward provincial priority clusters — applies elsewhere. Choose the reinvestment destination partly by matching your industry to the province’s priority list to capture factor guarantees and incentives.
  • Financing friction is falling. Panda bonds, delegated related-shareholder loan registration and the removal of account-opening steps for renminbi reinvestment lower the administrative cost of funding a reinvestment from profits.
  • Tax structuring needs care. The interaction between profit-reinvestment tax treatment, dividend withholding and the individual-tax rules for foreign shareholders (separately tightened from September 2026 for dividends to foreign individuals) should be modelled before distributing and reinvesting.
  • Reporting duties apply. The pilot on information reporting of domestic investment by FIEs means reinvestment transactions should be filed through the foreign-investment information-reporting system as applicable.

Practical steps

  • Identify which profits (undistributed vs distributed-but-not-repatriated; RMB vs FX) you plan to reinvest, and confirm the applicable tax treatment for each route.
  • Map your target industry against the priority sector lists of the province or municipality where the reinvestment will land.
  • For large reinvestments, request inclusion in the major/key foreign-investment project list or the local project bank to access tiered service.
  • Structure financing deliberately: evaluate panda-bond issuance, related-shareholder loan registration delegation and QFLP options against your group’s treasury model.
  • File the required investment information reports and keep the supporting documentation that reinvestment tax preferences demand.

Sources

  • 重庆市发展和改革委员会 — 关于印发《重庆市鼓励外商投资企业境内再投资若干措施》的通知(渝发改规范〔2026〕9号): https://www.fzggw.cq.gov.cn/zwgk/zfxxgkml/zcwj/xzgfxwj/sfzggwxzgfxwj/202609/t20260904_16034139.html
  • 重庆市人民政府网 — 重庆出台16条举措 鼓励外商投资企业境内再投资(政策解读): https://www.cq.gov.cn/ywdt/jrcq/202609/t20260905_16035870.html
  • 中华人民共和国商务部 — 外国投资管理(政策发布栏目,含《关于实施鼓励外商投资企业境内再投资若干措施的通知》等文件索引): https://www.mofcom.gov.cn:8443/zcfb/wgtzgl/index.html

Related reading

  • see also: how profit repatriation and outbound payments are taxed for FIEs (profit-repatriation)
  • see also: reinvestment and holding structures for foreign investors (fie-investment-company-regional-hq)

让利润留在中国:外资境内再投资框架与重庆2026版落地16条

概述

鼓励外商投资企业及其境外股东把利润留在中国境内再投资而非汇出,已连续三年写入政府工作报告的政策部署。国家层面架构依托2025年7月国家发展改革委等七部门印发的《关于实施鼓励外商投资企业境内再投资若干措施的通知》(发改外资〔2025〕928号),提出11项便利措施。

这一框架在2026年9月从国家指导走向地方实操。2026年9月4日,重庆市发展和改革委员会印发《重庆市鼓励外商投资企业境内再投资若干措施》(渝发改规范〔2026〕9号)——一份16条政策包,把国家政策细化为具体的产业引导、金融便利与服务保障。重庆是率先发布专项落地文件的直辖市之一,其措施为任何评估”利润留在哪里、如何再投资”的外企集团提供了有用参照。

“再投资”涵盖什么

依据国家通知与重庆措施,再投资包括:在中国境内依法设立的外商投资企业运用未分配利润,或境外投资者以境内合法分得的本外币利润:

  • 新设企业;
  • 增资现有企业;
  • 取得境内企业股份、股权、财产份额或其他类似权益;或
  • 投资项目。

定义宽到足以覆盖内生扩张、并购式投资与项目融资——外资”深耕”而非”退出”的主要路径。

国家框架:11项措施

2025年国家发展改革委牵头的通知依托四大支柱:

  • 项目服务保障。 符合条件的再投资项目可纳入重大和重点外资项目清单并享受相应支持政策,接入分级项目服务机制。
  • 土地要素。 优化再投资土地要素配置,包括弹性供给方式。
  • 简化流程。 简化以再投资为目的新设企业的办理流程。
  • 外汇与融资便利。 合法外汇利润可按规定境内划转用于再投资;拓宽融资渠道,外方关联股东贷款与”熊猫债”纳入”绿色通道”管理。

税收层与通知并行:按适用于境外投资者以分配利润境内直接投资的再投资税收优惠规则,符合条件的再投资可递延或抵免本应在股息分配环节产生的预提税负——由于该制度经2025年系列公告细化,投资者应向顾问确认现行实施口径。

重庆16条:产业引导×国民待遇

重庆版把16条措施组织为三个维度——引导投向、便利投资经营、提升保障水平,以内外资一致原则为骨架:

  • 投向引导。 引导再投资进入”33618″现代制造业集群体系(智能网联新能源汽车、新一代电子信息制造业、先进材料等赛道)、”9611″现代服务业体系(工业设计、供应链管理、知识产权运营、品牌营销、检验检测认证)以及”416″科技创新战略布局(研发中心、技术攻关、中试平台建设)。重庆确认制造业外资准入限制已”全面清零”,符合条件的外资再投资制造业项目按内外资一致原则同等享受要素保障与扶持政策。
  • 金融便利。 支持发行”熊猫债”;下放外方关联股东贷款签约登记权限;探索QFLP试点;取消资本项目人民币收入与境内人民币利润再投资对应的账户开立要求;鼓励银行优化外汇业务流程。重庆还支持符合条件的再投资项目申报超长期特别国债资金,并争取扩容《中西部等地区外商投资优势产业目录》重庆条目、衔接鼓励类税收优惠。
  • 服务保障。 建立外商投资企业境内再投资项目库,依托外资项目专班分级分类协调服务;修订营商环境条例、提升境外人员来渝工作生活便利;推进外商投资企业境内投资信息报告试点并完善跨部门信息共享;把境内再投资纳入外商投资促进成效评价。

对外资集团的意义

  • 再投资成为有管理、有服务支撑的通道。 从国家项目清单机制到地方项目库,符合所在省份产业地图的再投资可望获得比个案式扩张更快的协调。
  • 产业地图因省而异。 重庆的”33618/9611/416″是本地话语;同样的逻辑——把再投资导向省级优先集群——适用于各地。选择再投资目的地时,应部分依据本行业与该省优先清单的匹配度,以获取要素保障与激励。
  • 融资摩擦在下降。 “熊猫债”、关联股东贷款登记下放、取消人民币再投资开户步骤,降低了以利润注资再投资的行政成本。
  • 税务架构需要谨慎。 利润再投资税收优惠、股息预提税、以及外籍个人股东个税规则(2026年9月起外籍个人取得股息按20%征税已另行收紧)之间的互动,应在分配与再投资前测算。
  • 申报义务适用。 外商投资企业境内投资信息报告试点意味着再投资交易应按规定通过外商投资信息报告系统报送。

实务建议

  • 明确拟再投资的利润类别(未分配 vs 已分配未汇出;人民币 vs 外汇),逐条确认适用税收待遇。
  • 把目标行业与拟落地省市优先产业清单对照。
  • 大额再投资可申请纳入重大/重点外资项目清单或地方项目库,接入分级服务。
  • 审慎设计融资结构:对照集团财资模式评估熊猫债、关联股东贷款登记下放与QFLP选项。
  • 按规定办理投资信息报告,并留存再投资税收优惠所需的支持文件。

来源

  • 重庆市发展和改革委员会 — 关于印发《重庆市鼓励外商投资企业境内再投资若干措施》的通知(渝发改规范〔2026〕9号): https://www.fzggw.cq.gov.cn/zwgk/zfxxgkml/zcwj/xzgfxwj/sfzggwxzgfxwj/202609/t20260904_16034139.html
  • 重庆市人民政府网 — 重庆出台16条举措 鼓励外商投资企业境内再投资(政策解读): https://www.cq.gov.cn/ywdt/jrcq/202609/t20260905_16035870.html
  • 中华人民共和国商务部 — 外国投资管理(政策发布栏目,含《关于实施鼓励外商投资企业境内再投资若干措施的通知》等文件索引): https://www.mofcom.gov.cn:8443/zcfb/wgtzgl/index.html

相关阅读

  • 见:外商投资企业利润汇出与对外付款的税务处理(profit-repatriation)
  • 见:外资再投资与控股架构(fie-investment-company-regional-hq)